{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:02:57Z","timestamp":1790607777825,"version":"4.1.0"},"reference-count":369,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05772-5","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:06:15Z","timestamp":1774278375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2018-8402","authenticated-orcid":false,"given":"Shubham","family":"Upadhayay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"4","key":"5772_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jnnp-2024-334767","volume":"96","author":"SA Finkelstein","year":"2025","unstructured":"Finkelstein SA, Diamond C, Carson A, Stone J (2025) Incidence and prevalence of functional neurological disorder: a systematic review. J Neurol Neurosurg Psychiatry 96(4):383\u2013395","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"5772_CR2","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/S2468-2667(25)00089-1","volume":"10","author":"A Mitchell","year":"2025","unstructured":"Mitchell A, Cogswell IE, Dalos J, Tsakalos G, Lei J, Oros A, Rafferty Q, Santoni S et al (2025) Estimating global direct health-care spending on neurological and mental health between 2000 and 2019: a modelling study. Lancet Public Health 10(5):e401\u2013e411","journal-title":"Lancet Public Health"},{"issue":"11","key":"5772_CR3","doi-asserted-by":"publisher","first-page":"14367","DOI":"10.1007\/s12035-025-04962-x","volume":"62","author":"S Upadhayay","year":"2025","unstructured":"Upadhayay S, Soni D, Dhureja M, Temgire P, Kumar V, Arthur R, Kumar P (2025) Role of fibroblast growth factors in neurological disorders: insight into therapeutic approaches and molecular mechanisms. Mol Neurobiol 62(11):14367\u201314386. https:\/\/doi.org\/10.1007\/s12035-025-04962-x","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5772_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3233\/jad-131799","volume":"41","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Zhao H, Lobo N, Guo X, Gentleman SM, Ma D (2014) Celastrol enhances cell viability and inhibits amyloid-\u03b2 production induced by lipopolysaccharide in vitro. J Alzheimers Dis 41(3):835\u2013844. https:\/\/doi.org\/10.3233\/jad-131799","journal-title":"J Alzheimers Dis"},{"key":"5772_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding C, Wu Y, Chen X, Chen Y, Wu Z, Lin Z, Kang D, Fang W et al (2022) Global, regional, and national burden and attributable risk factors of neurological disorders: the Global Burden of Disease study 1990\u20132019. Front Public Health 10:952161. https:\/\/doi.org\/10.3389\/fpubh.2022.952161","journal-title":"Front Public Health"},{"key":"5772_CR6","doi-asserted-by":"publisher","first-page":"1542369","DOI":"10.3389\/fimmu.2025.1542369","volume":"16","author":"Y Ma","year":"2025","unstructured":"Ma Y, Song R, Duan C (2025) Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation. Front Immunol 16:1542369. https:\/\/doi.org\/10.3389\/fimmu.2025.1542369","journal-title":"Front Immunol"},{"issue":"4","key":"5772_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1192\/bjp.2024.266","volume":"227","author":"J Rong","year":"2025","unstructured":"Rong J, Wang X, Cheng P, Li D, Zhao D (2025) Global, regional and national burden of depressive disorders and attributable risk factors, from 1990 to 2021: results from the 2021 Global Burden of Disease study. Br J Psychiatry 227(4):688\u2013697. https:\/\/doi.org\/10.1192\/bjp.2024.266","journal-title":"Br J Psychiatry"},{"key":"5772_CR8","unstructured":"Organization PAH (2021) PAHO. The burden of Neurological conditions in the Region of the Americas, 2000\u20132019. Pan American Health Organization. https:\/\/www.paho.org\/en\/enlace\/burden-neurological-conditions"},{"key":"5772_CR9","doi-asserted-by":"publisher","unstructured":"Zhang C, Yang X, Wan D, Ma Q, Yin P, Zhou M, Hao J (2025) Burden of neurological disorders in China and its provinces, 1990\u20132021: findings from the global burden of disease study 2021. Med (New York, N.Y.) 6(8):100692. https:\/\/doi.org\/10.1016\/j.medj.2025.100692","DOI":"10.1016\/j.medj.2025.100692"},{"issue":"1","key":"5772_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14737175.2024.2440543","volume":"25","author":"E C\u00e1ceres","year":"2025","unstructured":"C\u00e1ceres E, Divani AA, Vi\u00f1an-Garces AE, Olivella-Gomez J, Quintero-Altare A, P\u00e9rez S, Reyes LF, Sasso N et al (2025) Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature. Expert Rev Neurother 25(1):67\u201383","journal-title":"Expert Rev Neurother"},{"key":"5772_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117184","volume":"284","author":"G Huang","year":"2025","unstructured":"Huang G, Lin Y, Zhao J, Zhang J, Du Y, Xiao M, Li H, Chen Z et al (2025) Corosolic acid and its derivatives targeting MCCC1 against insulin resistance and their hypoglycemic effect on type 2 diabetic mice. Eur J Med Chem 284:117184","journal-title":"Eur J Med Chem"},{"issue":"1","key":"5772_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12883-025-04174-9","volume":"25","author":"T Elboraay","year":"2025","unstructured":"Elboraay T, Ebada MA, Elsayed M, Aboeldahab HA, Salamah HM, Rageh O, Elmallahy M, AboElfarh HE et al (2025) Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients. BMC Neurol 25(1):250","journal-title":"BMC Neurol"},{"issue":"2","key":"5772_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/metabo15020124","volume":"15","author":"EP de Lima","year":"2025","unstructured":"de Lima EP, Laurindo LF, Catharin VCS, Direito R, Tanaka M, Jasmin Santos German I, Lamas CB, Guiguer EL et al (2025) Polyphenols, alkaloids, and terpenoids against neurodegeneration: evaluating the neuroprotective effects of phytocompounds through a comprehensive review of the current evidence. Metabolites 15(2):124","journal-title":"Metabolites"},{"key":"5772_CR14","doi-asserted-by":"publisher","unstructured":"Maurya P, Pathak D, Gupta R, Maurya NK, Singh G (2025) Traditional herbal approaches used for neurological disorders. In: The nature of nutraceuticals. Apple Academic Press\u00a01:393\u2013405. https:\/\/doi.org\/10.1201\/9781003518969-18","DOI":"10.1201\/9781003518969-18"},{"issue":"1","key":"5772_CR15","doi-asserted-by":"publisher","first-page":"3675425","DOI":"10.1155\/agm3\/3675425","volume":"2025","author":"PM Reque","year":"2025","unstructured":"Reque PM, Brandelli A, Miyazaki CMS, Pessoa AFM (2025) Medicinal plants and herbal medicines for managing anxiety and depression via gut microbiota modulation. Advanced Gut & Microbiome Research 2025(1):3675425","journal-title":"Advanced Gut & Microbiome Research"},{"issue":"3","key":"5772_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1039\/c0np00059k","volume":"28","author":"H Sheng","year":"2011","unstructured":"Sheng H, Sun H (2011) Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases. Nat Prod Rep 28(3):543\u2013593. https:\/\/doi.org\/10.1039\/c0np00059k","journal-title":"Nat Prod Rep"},{"key":"5772_CR17","doi-asserted-by":"publisher","unstructured":"Cheng YG, Li JL, Li P, Yang SQ, Zang Y, Wang Y, Yu YT, Xie X et al (2025) Neuroprotective triterpenoids from Astragalus membranaceus stems and leaves: anti-inflammatory and anti-apoptotic mechanisms for memory improvement via in vivo and in vitro models. Bioorg Chem 160:108492. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108492","DOI":"10.1016\/j.bioorg.2025.108492"},{"key":"5772_CR18","doi-asserted-by":"publisher","unstructured":"Parvez A, Rahman MA, Rahman MM, Shimki AI, Ahmmed S, Supti FA, Hasan MH, Bristi MSA et al (2025) Broad-spectrum therapeutic potentials of the multifaceted triterpene lupeol and its derivatives. Chem Biodiver 22(7):e202402286. https:\/\/doi.org\/10.1002\/cbdv.202402286","DOI":"10.1002\/cbdv.202402286"},{"issue":"8","key":"5772_CR19","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1039\/D2NP00063F","volume":"40","author":"Y Li","year":"2023","unstructured":"Li Y, Wang J, Li L, Song W, Li M, Hua X, Wang Y, Yuan J et al (2023) Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis. Nat Prod Rep 40(8):1303\u20131353","journal-title":"Nat Prod Rep"},{"issue":"2","key":"5772_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s13580-023-00561-8","volume":"65","author":"DH Min","year":"2024","unstructured":"Min DH, Yu YB, Kim TH, Kim H, Lee S (2024) Pharmacological effects of pentacyclic triterpenoids isolated from Centella asiatica. Hortic Environ Biotechnol 65(2):189\u2013197","journal-title":"Hortic Environ Biotechnol"},{"issue":"5","key":"5772_CR21","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1007\/s11101-024-10056-8","volume":"24","author":"J Malik","year":"2024","unstructured":"Malik J, Mandal SC (2024) Pentacyclic triterpenoids: diversity, distribution and their propitious pharmacological potential. Phytochem Rev 24(5):4791\u20134823. https:\/\/doi.org\/10.1007\/s11101-024-10056-8","journal-title":"Phytochem Rev"},{"issue":"17","key":"5772_CR22","doi-asserted-by":"publisher","first-page":"9615","DOI":"10.3390\/ijms25179615","volume":"25","author":"L Apaza Ticona","year":"2024","unstructured":"Apaza Ticona L, S\u00e1nchez S\u00e1nchez-Corral J, Montoto Lozano N, Prieto Ramos P, S\u00e1nchez \u00c1R (2024) Study of pentacyclic triterpenes from lyophilised Aguaje: anti-inflammatory and antioxidant properties. Int J Mol Sci 25(17):9615","journal-title":"Int J Mol Sci"},{"key":"5772_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113637","volume":"268","author":"JP Dzoyem","year":"2021","unstructured":"Dzoyem JP, Nganteng DND, Melong R, Wafo P, Ngadjui B, All\u00e9mann E, Delie F (2021) Bioguided identification of pentacyclic triterpenoids as anti-inflammatory bioactive constituents of Ocimum gratissimum extract. J Ethnopharmacol 268:113637","journal-title":"J Ethnopharmacol"},{"key":"5772_CR24","doi-asserted-by":"crossref","unstructured":"Miranda RdS, de Jesus BdSM, da Silva Luiz SR, Viana CB, Adao Malafaia CR, Figueiredo FdS, Carvalho TdSC, Silva ML et al. (2022) Antiinflammatory activity of natural triterpenes\u2014an overview from 2006 to 2021. Phytother Res 36(4):1459\u20131506","DOI":"10.1002\/ptr.7359"},{"issue":"4","key":"5772_CR25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1080\/01480545.2021.1880427","volume":"45","author":"KMA Abdullah","year":"2022","unstructured":"Abdullah KMA, Ahmad W, Ahmad M, Adhikari A, Ibrar M, Rehman Mu, Asif M (2022) Antioxidant, antinociceptive, anti-inflammatory, and hepatoprotective activities of pentacyclic triterpenes isolated from Ziziphus oxyphylla Edgew. Drug Chem Toxicol 45(4):1796\u20131807","journal-title":"Drug Chem Toxicol"},{"key":"5772_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8512048","volume":"2019","author":"S Habtemariam","year":"2019","unstructured":"Habtemariam S (2019) Antioxidant and anti-inflammatory mechanisms of neuroprotection by ursolic acid: addressing brain injury, cerebral ischemia, cognition deficit, anxiety, and depression. Oxid Med Cell Longev 2019:8512048. https:\/\/doi.org\/10.1155\/2019\/8512048","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5772_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11064-024-04319-1","volume":"50","author":"M Aqeel","year":"2025","unstructured":"Aqeel M, Upadhayay S, Devi R, Jangid K, Kumar V, Kumar P (2025) Glycyrrhizic acid mitigates haloperidol-induced neurotoxicity in SHSY-5Y cells and rats via activation of PI3k\/Akt\/Nrf2 pathways. Neurochem Res 50(1):75. https:\/\/doi.org\/10.1007\/s11064-024-04319-1","journal-title":"Neurochem Res"},{"key":"5772_CR28","doi-asserted-by":"publisher","first-page":"1189372","DOI":"10.3389\/fphar.2023.1189372","volume":"14","author":"Y Fu","year":"2023","unstructured":"Fu Y, Liu T, He S, Zhang Y, Tan Y, Bai Y, Shi J, Deng W et al (2023) Ursolic acid reduces oxidative stress injury to ameliorate experimental autoimmune myocarditis by activating Nrf2\/HO-1 signaling pathway. Front Pharmacol 14:1189372. https:\/\/doi.org\/10.3389\/fphar.2023.1189372","journal-title":"Front Pharmacol"},{"key":"5772_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172610","volume":"861","author":"H Yu","year":"2019","unstructured":"Yu H, Li W, Cao X, Wang X, Zhao Y, Song L, Chen J, Wang S et al (2019) Echinocystic acid, a natural plant extract, alleviates cerebral ischemia\/reperfusion injury via inhibiting the JNK signaling pathway. Eur J Pharmacol 861:172610. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172610","journal-title":"Eur J Pharmacol"},{"key":"5772_CR30","doi-asserted-by":"publisher","first-page":"1103265","DOI":"10.3389\/fphar.2023.1103265","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Chen L, Zheng D, Liu JX, Liu C, Qi SH, Hu PC, Yang XF et al (2023) Echinocystic acid alleviated hypoxic-ischemic brain damage in neonatal mice by activating the PI3K\/Akt\/Nrf2 signaling pathway. Front Pharmacol 14:1103265. https:\/\/doi.org\/10.3389\/fphar.2023.1103265","journal-title":"Front Pharmacol"},{"key":"5772_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113298","volume":"265","author":"S Ac\u00edn","year":"2021","unstructured":"Ac\u00edn S, Mu\u00f1oz DL, Guillen A, Soscue D, Casta\u00f1o A, Echeverri F, Balcazar N (2021) Triterpene-enriched fractions from Eucalyptus tereticornis ameliorate metabolic alterations in a mouse model of diet-induced obesity. J Ethnopharmacol 265:113298","journal-title":"J Ethnopharmacol"},{"key":"5772_CR32","unstructured":"da Silva Ferreira RG, Guilhon-Simplicio F, Acho LDR, Batista NY, do Carmo Guedes-Junior F, Ferreira MSL, Barcellos JFM, Veiga-Junior VF et al (2021) Anti-hyperglycemic, lipid-lowering, and anti-obesity effects of the triterpenes \u03b1 and \u03b2-amyrenones in vivo. Avicenna J Phytomed 11(5):451"},{"issue":"23","key":"5772_CR33","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.3390\/molecules26237243","volume":"26","author":"M Oboh","year":"2021","unstructured":"Oboh M, Govender L, Siwela M, Mkhwanazi BN (2021) Anti-diabetic potential of plant-based pentacyclic triterpene derivatives: progress made to improve efficacy and bioavailability. Molecules 26(23):7243","journal-title":"Molecules"},{"issue":"1","key":"5772_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28010272","volume":"28","author":"P Yao","year":"2022","unstructured":"Yao P, Liu Y (2022) Terpenoids: natural compounds for non-alcoholic fatty liver disease (NAFLD) therapy. Molecules 28(1):272","journal-title":"Molecules"},{"key":"5772_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177276","volume":"990","author":"X Li","year":"2025","unstructured":"Li X, Zhang Y, Chen L, Xu X, Ma X, Lou S, Zou Z, Wang C et al (2025) Actichinone, a new ursane triterpenoid from Actinidia chinensis roots, ameliorates NAFLD via the AMPK and NF-\u03baB pathways. Eur J Pharmacol 990:177276","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5772_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.62940\/als.v9i2.1422","volume":"9","author":"S Javed","year":"2022","unstructured":"Javed S, Javaid I, Shoaib A, Perveen S (2022) Oleanolic acid (pentacyclic triterpenes) as a potential candidate for \u03b1-glycosidase inhibition activity. Advancements in life sciences 9(2):219\u2013223","journal-title":"Advancements in life sciences"},{"issue":"8","key":"5772_CR37","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1002\/ptr.70030","volume":"39","author":"N Randeni","year":"2025","unstructured":"Randeni N, Luo J, Xu B (2025) Unveiling the molecular mechanisms of natural triterpenoids from mushrooms against type 2 diabetes: a critical review. Phytother Res 39(8):3466\u20133485. https:\/\/doi.org\/10.1002\/ptr.70030","journal-title":"Phytother Res"},{"issue":"8","key":"5772_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12272-024-01510-4","volume":"47","author":"D Peng","year":"2024","unstructured":"Peng D, Wang A, Shi W, Lin L (2024) Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases. Arch Pharm Res 47(8):709\u2013735","journal-title":"Arch Pharm Res"},{"issue":"12","key":"5772_CR39","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/cmdc.202100038","volume":"16","author":"DR Barreto Vianna","year":"2021","unstructured":"Barreto Vianna DR, Gotardi J, Baggio Gnoatto SC, Pilger DA (2021) Natural and semisynthetic pentacyclic triterpenes for chronic myeloid leukemia therapy: reality, challenges and perspectives. ChemMedChem 16(12):1835\u20131860","journal-title":"ChemMedChem"},{"issue":"1","key":"5772_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11095-022-03428-2","volume":"40","author":"T Halder","year":"2023","unstructured":"Halder T, Patel B, Acharya N (2023) Asiatic acid fabricated nanoconstructs to mitigate amyloid beta(1\u201342) induced injury in SH-SY5Y cells in-vitro and ameliorates cognitive impairment by dual cholinesterase inhibition and attenuation of oxidative stress in-vivo. Pharm Res 40(1):197\u2013213. https:\/\/doi.org\/10.1007\/s11095-022-03428-2","journal-title":"Pharm Res"},{"key":"5772_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00028","volume":"9","author":"D Song","year":"2018","unstructured":"Song D, Jiang X, Liu Y, Sun Y, Cao S, Zhang Z (2018) Asiaticoside attenuates cell growth inhibition and apoptosis induced by A\u03b2(1-42) via inhibiting the TLR4\/NF-\u03baB signaling pathway in human brain microvascular endothelial cells. Front Pharmacol 9:28. https:\/\/doi.org\/10.3389\/fphar.2018.00028","journal-title":"Front Pharmacol"},{"issue":"11\u201312","key":"5772_CR42","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s12031-023-02160-9","volume":"73","author":"K Li","year":"2023","unstructured":"Li K, Wang Y, Ni H (2023) Hederagenin upregulates PTPN1 expression in A\u03b2-stimulated neuronal cells, exerting anti-oxidative stress and anti-apoptotic activities. J Mol Neurosci 73(11\u201312):932\u2013945. https:\/\/doi.org\/10.1007\/s12031-023-02160-9","journal-title":"J Mol Neurosci"},{"key":"5772_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuro.2020.12.015","volume":"83","author":"S Sharma","year":"2021","unstructured":"Sharma S, Saini A, Nehru B (2021) Neuroprotective effects of carbenoxolone against amyloid-beta 1\u201342 oligomer-induced neuroinflammation and cognitive decline in rats. Neurotoxicology 83:89\u2013105. https:\/\/doi.org\/10.1016\/j.neuro.2020.12.015","journal-title":"Neurotoxicology"},{"key":"5772_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115234","volume":"292","author":"Q Ren","year":"2022","unstructured":"Ren Q, Jiang X, Paudel YN, Gao X, Gao D, Zhang P, Sheng W, Shang X et al (2022) Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson\u2019s disease like pathology in Zebrafish. J Ethnopharmacol 292:115234. https:\/\/doi.org\/10.1016\/j.jep.2022.115234","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"5772_CR45","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s11064-017-2183-2","volume":"42","author":"J Nataraj","year":"2017","unstructured":"Nataraj J, Manivasagam T, Justin Thenmozhi A, Essa MM (2017) Neurotrophic effect of asiatic acid, a triterpene of centella asiatica against chronic 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine hydrochloride\/probenecid mouse model of Parkinson\u2019s disease: the role of MAPK, PI3K-Akt-GSK3\u03b2 and mTOR signalling pathways. Neurochem Res 42(5):1354\u20131365. https:\/\/doi.org\/10.1007\/s11064-017-2183-2","journal-title":"Neurochem Res"},{"key":"5772_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.brainresbull.2020.03.003","volume":"160","author":"V Peshattiwar","year":"2020","unstructured":"Peshattiwar V, Muke S, Kaikini A, Bagle S, Dighe V, Sathaye S (2020) Mechanistic evaluation of Ursolic acid against rotenone induced Parkinson\u2019s disease- emphasizing the role of mitochondrial biogenesis. Brain Res Bull 160:150\u2013161. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.03.003","journal-title":"Brain Res Bull"},{"issue":"4","key":"5772_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/15376516.2023.2288198","volume":"34","author":"TD Pingale","year":"2024","unstructured":"Pingale TD, Gupta GL (2024) Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathways. Toxicol Mech Methods 34(4):335\u2013349. https:\/\/doi.org\/10.1080\/15376516.2023.2288198","journal-title":"Toxicol Mech Methods"},{"issue":"2","key":"5772_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","volume":"49","author":"C Stack","year":"2010","unstructured":"Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M et al (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington\u2019s disease. Free Radic Biol Med 49(2):147\u2013158. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.03.017","journal-title":"Free Radic Biol Med"},{"key":"5772_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121317","volume":"314","author":"AM Gendy","year":"2023","unstructured":"Gendy AM, El-Sadek HM, Amin MM, Ahmed KA, El-Sayed MK, El-Haddad AE, Soubh A (2023) Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1\/TLR4\/NF-\u03baB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats. Life Sci 314:121317. https:\/\/doi.org\/10.1016\/j.lfs.2022.121317","journal-title":"Life Sci"},{"issue":"2","key":"5772_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2010.04.009","volume":"49","author":"C Escartin","year":"2010","unstructured":"Escartin C, Brouillet E (2010) The Nrf2 pathway as a potential therapeutic target for Huntington disease A commentary on \u201cTriterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease.\u201d Free Radic Biol Med 49(2):144\u2013146. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.04.009","journal-title":"Free Radic Biol Med"},{"key":"5772_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.eplepsyres.2017.11.003","volume":"139","author":"ZH Wang","year":"2018","unstructured":"Wang ZH, Mong MC, Yang YC, Yin MC (2018) Asiatic acid and maslinic acid attenuated kainic acid-induced seizure through decreasing hippocampal inflammatory and oxidative stress. Epilepsy Res 139:28\u201334. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.003","journal-title":"Epilepsy Res"},{"key":"5772_CR52","doi-asserted-by":"publisher","unstructured":"Kim JE, Park H, Kang TC (2020) CDDO-Me distinctly regulates regional specific astroglial responses to status epilepticus via ERK1\/2-Nrf2, PTEN-PI3K-AKT and NF\u03baB signaling pathways. Antioxidants (Basel) 9(10). https:\/\/doi.org\/10.3390\/antiox9101026","DOI":"10.3390\/antiox9101026"},{"key":"5772_CR53","doi-asserted-by":"publisher","unstructured":"Umka Welbat J, Sirichoat A, Chaijaroonkhanarak W, Prachaney P, Pannangrong W, Pakdeechote P, Sripanidkulchai B, Wigmore P (2016) Asiatic acid prevents the deleterious effects of valproic acid on cognition and hippocampal cell proliferation and survival. Nutrients 8(5). https:\/\/doi.org\/10.3390\/nu8050303","DOI":"10.3390\/nu8050303"},{"key":"5772_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.eplepsyres.2016.07.007","volume":"126","author":"S Gonz\u00e1lez-Reyes","year":"2016","unstructured":"Gonz\u00e1lez-Reyes S, Santill\u00e1n-Cigales JJ, Jim\u00e9nez-Osorio AS, Pedraza-Chaverri J, Guevara-Guzm\u00e1n R (2016) Glycyrrhizin ameliorates oxidative stress and inflammation in hippocampus and olfactory bulb in lithium\/pilocarpine-induced status epilepticus in rats. Epilepsy Res 126:126\u2013133. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.07.007","journal-title":"Epilepsy Res"},{"issue":"2","key":"5772_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12031-024-02289-1","volume":"75","author":"D Sharma","year":"2025","unstructured":"Sharma D, Walia S, Kaur S, Kapil L, Singh C, Singh A (2025) Ursolic acid and caprylic acid cocktail approach against pentylenetetrazole-induced seizures-like behavior in adult zebrafish: preclinical study. J Mol Neurosci 75(2):59. https:\/\/doi.org\/10.1007\/s12031-024-02289-1","journal-title":"J Mol Neurosci"},{"key":"5772_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113072","volume":"151","author":"F Abbas","year":"2022","unstructured":"Abbas F, Eladl MA, El-Sherbiny M, Abozied N, Nabil A, Mahmoud SM, Mokhtar HI, Zaitone SA et al (2022) Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain. Biomed Pharmacother 151:113072. https:\/\/doi.org\/10.1016\/j.biopha.2022.113072","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5772_CR57","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1007\/s12035-024-04657-9","volume":"62","author":"J Lou","year":"2025","unstructured":"Lou J, Ding B, Fang M, Xie W, Wang X, Wang X, Guo X, Zhu J (2025) Glycyrrhizin attenuates white matter injury by inhibiting neuroinflammation through the HMGB1\/TLR4 pathway. Mol Neurobiol 62(5):6070\u20136087. https:\/\/doi.org\/10.1007\/s12035-024-04657-9","journal-title":"Mol Neurobiol"},{"key":"5772_CR58","doi-asserted-by":"publisher","first-page":"177063","DOI":"10.1016\/j.ejphar.2024.177063","volume":"984","author":"F Liu","year":"2024","unstructured":"Liu F, Jia Y, Zhao L, Xiao LN, Cheng X, Xiao Y, Zhang Y, Zhang Y et al (2024) Escin ameliorates CUMS-induced depressive-like behavior via BDNF\/TrkB\/CREB and TLR4\/MyD88\/NF-\u03baB signaling pathways in rats. Eur J Pharmacol 984:177063. https:\/\/doi.org\/10.1016\/j.ejphar.2024.177063","journal-title":"Eur J Pharmacol"},{"key":"5772_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbi.2023.09.026","volume":"115","author":"X Zhang","year":"2024","unstructured":"Zhang X, He T, Wu Z, Wang Y, Liu H, Zhang B, Yang S, Wang D et al (2024) The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine. Brain Behav Immun 115:64\u201379. https:\/\/doi.org\/10.1016\/j.bbi.2023.09.026","journal-title":"Brain Behav Immun"},{"key":"5772_CR60","doi-asserted-by":"publisher","unstructured":"Webster KM, Shultz SR, Ozturk E, Dill LK, Sun M, Casillas-Espinosa P, Jones NC, Crack PJ et al (2019) Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: chronic neuroinflammatory, behavioral, and epileptogenic consequences. Exp Neurol 320:112979. https:\/\/doi.org\/10.1016\/j.expneurol.2019.112979","DOI":"10.1016\/j.expneurol.2019.112979"},{"key":"5772_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.114987","volume":"382","author":"X Bu","year":"2024","unstructured":"Bu X, Guo H, Gao W, Zhang L, Hou J, Li B, Xia Z, Wang W (2024) Neuroprotection of celastrol against postoperative cognitive dysfunction through dampening cGAS-STING signaling. Exp Neurol 382:114987. https:\/\/doi.org\/10.1016\/j.expneurol.2024.114987","journal-title":"Exp Neurol"},{"key":"5772_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-14","volume":"5","author":"TA Tran","year":"2008","unstructured":"Tran TA, McCoy MK, Sporn MB, Tansey MG (2008) The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection. J Neuroinflammation 5:14. https:\/\/doi.org\/10.1186\/1742-2094-5-14","journal-title":"J Neuroinflammation"},{"issue":"3","key":"5772_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/1028415X.2023.2180865","volume":"27","author":"M Farzan","year":"2024","unstructured":"Farzan M, Farzan M, Shahrani M, Navabi SP, Vardanjani HR, Amini-Khoei H, Shabani S (2024) Neuroprotective properties of betulin, betulinic acid, and ursolic acid as triterpenoids derivatives: a comprehensive review of mechanistic studies. Nutr Neurosci 27(3):223\u2013240","journal-title":"Nutr Neurosci"},{"issue":"1","key":"5772_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12035-014-8769-7","volume":"51","author":"P Thakur","year":"2015","unstructured":"Thakur P, Nehru B (2015) Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson\u2019s disease. Mol Neurobiol 51(1):209\u2013219. https:\/\/doi.org\/10.1007\/s12035-014-8769-7","journal-title":"Mol Neurobiol"},{"key":"5772_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.877898","volume":"13","author":"KM Liu","year":"2022","unstructured":"Liu KM, Huang Y, Wan PP, Lu YH, Zhou N, Li JJ, Yu CY, Chou JJ, Zhang L, Zhang C, Qiang YY, Zhang R, Guo L (2022) Ursolic acid protects neurons in temporal lobe epilepsy and cognitive impairment by repressing inflammation and oxidation. Front Pharmacol 13:877898. https:\/\/doi.org\/10.3389\/fphar.2022.877898","journal-title":"Front Pharmacol"},{"issue":"3","key":"5772_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jdad2030023","volume":"2","author":"L Moll","year":"2025","unstructured":"Moll L, H\u00e4ner M, R\u00f6ssler R, Krumm S (2025) Comparison of physical activity patterns between individuals with early-stage Alzheimer\u2019s disease and cognitively healthy adults. J Dement Alzheimer Dis 2(3):23","journal-title":"J Dement Alzheimer Dis"},{"key":"5772_CR67","doi-asserted-by":"publisher","unstructured":"Choi SH, Kim S, Ong PA, Chin AV, Dominguez J, Chen CLH, Senanarong V, Hu CJ et al (2025) The patient pathway for mild cognitive impairment due to Alzheimer\u2019s disease in Asia: current practices, barriers, and expert recommendations for optimization. J Prev Alzheimer\u2019s Dis 12(7):100215. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100215","DOI":"10.1016\/j.tjpad.2025.100215"},{"key":"5772_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01785-9","volume":"17","author":"E Gl\u00e4ser","year":"2025","unstructured":"Gl\u00e4ser E, Kilimann I, Platen M, Hoffmann W, Brosseron F, Buerger K, Coenjaerts M, D\u00fczel E, Ewers M, Fliessbach K (2025) The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer\u2019s dementia: excess costs and associated clinical and risk factors. Alzheimers Res Ther 17:142","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"5772_CR69","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1021\/acsomega.4c05527","volume":"10","author":"R Reddi Sree","year":"2025","unstructured":"Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla VR, Sakharkar MK, Song B-J, Chidambaram SB (2025) Newer therapeutic approaches in treating Alzheimer\u2019s disease: a comprehensive review. ACS Omega 10(6):5148\u20135171","journal-title":"ACS Omega"},{"issue":"6","key":"5772_CR70","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1007\/s12035-024-04654-y","volume":"62","author":"AG Almutary","year":"2025","unstructured":"Almutary AG, Begum MY, Siddiqua A, Gupta S, Chauhan P, Wadhwa K, Singh G, Iqbal D et al (2025) Unlocking the neuroprotective potential of silymarin: a promising ally in safeguarding the brain from Alzheimer\u2019s disease and other neurological disorders. Mol Neurobiol 62(6):7975\u20137997. https:\/\/doi.org\/10.1007\/s12035-024-04654-y","journal-title":"Mol Neurobiol"},{"issue":"7","key":"5772_CR71","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(25)00158-9","volume":"24","author":"S Janelidze","year":"2025","unstructured":"Janelidze S, Collij LE, Mattsson-Carlgren N, Antill A, Laymon CM, Lott I, Rosas HD, Minhas DS et al (2025) Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study. Lancet Neurol 24(7):591\u2013600","journal-title":"Lancet Neurol"},{"issue":"5","key":"5772_CR72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1474-4422(25)00085-7","volume":"24","author":"E Matar","year":"2025","unstructured":"Matar E, Halliday GM (2025) Biological effects of pathologies in Lewy body diseases: why timing matters. Lancet Neurol 24(5):441\u2013455","journal-title":"Lancet Neurol"},{"issue":"10","key":"5772_CR73","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/antiox13101208","volume":"13","author":"H Fanlo-Ucar","year":"2024","unstructured":"Fanlo-Ucar H, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, Ill-Raga G, Mu\u00f1oz FJ (2024) The dual role of amyloid Beta-Peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer\u2019s disease etiopathology. Antioxidants 13(10):1208","journal-title":"Antioxidants"},{"key":"5772_CR74","doi-asserted-by":"publisher","first-page":"1397901","DOI":"10.3389\/fnagi.2024.1397901","volume":"16","author":"M Kramer","year":"2024","unstructured":"Kramer M, Hoang T-H, Yang H, Shchyglo O, B\u00f6ge J, Neubacher U, Colitti-Klausnitzer J, Manahan-Vaughan D (2024) Intracerebral inoculation of healthy non-transgenic rats with a single aliquot of oligomeric amyloid-\u03b2 (1\u201342) profoundly and progressively alters brain function throughout life. Front Aging Neurosci 16:1397901","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"5772_CR75","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41582-021-00505-9","volume":"17","author":"M Romoli","year":"2021","unstructured":"Romoli M, Sen A, Parnetti L, Calabresi P, Costa C (2021) Amyloid-\u03b2: a potential link between epilepsy and cognitive decline. Nat Rev Neurol 17(8):469\u2013485","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5772_CR76","doi-asserted-by":"publisher","first-page":"4759963","DOI":"10.1155\/2022\/4759963","volume":"2022","author":"SU Nabi","year":"2022","unstructured":"Nabi SU, Khan A, Siddiqui EM, Rehman MU, Alshahrani S, Arafah A, Mehan S, Alsaffar RM, Alexiou A, Shen B (2022) Mechanisms of mitochondrial malfunction in Alzheimer\u2019s disease: new therapeutic hope. Oxid Med Cell Longev 2022(1):4759963","journal-title":"Oxid Med Cell Longev"},{"key":"5772_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149599","volume":"1857","author":"F Akbari","year":"2025","unstructured":"Akbari F, Soheilian R, Tavalaeian S, Zamani A, Mahdevar M (2025) Alterations in NFAT5 and ATP6V1E1 expression as potential diagnostic biomarkers in blood and brain for Alzheimer\u2019s disease: a study of gene overlap. Brain Res 1857:149599. https:\/\/doi.org\/10.1016\/j.brainres.2025.149599","journal-title":"Brain Res"},{"issue":"9","key":"5772_CR78","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1007\/s12035-024-04011-z","volume":"61","author":"J Wang","year":"2024","unstructured":"Wang J, Huo X, Zhou H, Liu H, Li X, Lu N, Sun X (2024) Identification of autophagy-related candidate genes in the early diagnosis of Alzheimer\u2019s disease and exploration of potential molecular mechanisms. Mol Neurobiol 61(9):6584\u20136598. https:\/\/doi.org\/10.1007\/s12035-024-04011-z","journal-title":"Mol Neurobiol"},{"key":"5772_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2024.114778","volume":"290","author":"JN Manfredi","year":"2025","unstructured":"Manfredi JN, Gupta SK, Vyavahare S, Deak F, Lu X, Buddha L, Wankhade U, Lohakare J, Isales C, Fulzele S (2025) Gut microbiota dysbiosis in Alzheimer\u2019s disease (AD): insights from human clinical studies and the mouse AD models. Physiol Behav 290:114778","journal-title":"Physiol Behav"},{"key":"5772_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101317","volume":"68","author":"X-h Qian","year":"2021","unstructured":"Qian X-h, Song X-x, Liu X-l, Chen S-d, Tang H-d (2021) Inflammatory pathways in Alzheimer\u2019s disease mediated by gut microbiota. Ageing Res Rev 68:101317","journal-title":"Ageing Res Rev"},{"key":"5772_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00892","volume":"9","author":"MF Nagoor Meeran","year":"2018","unstructured":"Nagoor Meeran MF, Goyal SN, Suchal K, Sharma C, Patil CR, Ojha SK (2018) Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: a pentacyclic triterpenoid of therapeutic promise. Front Pharmacol 9:892. https:\/\/doi.org\/10.3389\/fphar.2018.00892","journal-title":"Front Pharmacol"},{"key":"5772_CR82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.lfs.2018.07.016","volume":"208","author":"W Cheng","year":"2018","unstructured":"Cheng W, Chen W, Wang P, Chu J (2018) Asiatic acid protects differentiated PC12 cells from A\u03b2(25\u201335)-induced apoptosis and tau hyperphosphorylation via regulating PI3K\/Akt\/GSK-3\u03b2 signaling. Life Sci 208:96\u2013101. https:\/\/doi.org\/10.1016\/j.lfs.2018.07.016","journal-title":"Life Sci"},{"issue":"7","key":"5772_CR83","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/s0278-5846(01)00192-0","volume":"25","author":"AC Allison","year":"2001","unstructured":"Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 25(7):1341\u20131357. https:\/\/doi.org\/10.1016\/s0278-5846(01)00192-0","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5772_CR84","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2017.10.002","volume":"337","author":"SP Navabi","year":"2018","unstructured":"Navabi SP, Sarkaki A, Mansouri E, Badavi M, Ghadiri A, Farbood Y (2018) The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer\u2019s disease. Behav Brain Res 337:99\u2013106. https:\/\/doi.org\/10.1016\/j.bbr.2017.10.002","journal-title":"Behav Brain Res"},{"key":"5772_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-2094-7-17","volume":"7","author":"D Paris","year":"2010","unstructured":"Paris D, Ganey NJ, Laporte V, Patel NS, Beaulieu-Abdelahad D, Bachmeier C, March A, Ait-Ghezala G, Mullan MJ (2010) Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation 7:17. https:\/\/doi.org\/10.1186\/1742-2094-7-17","journal-title":"J Neuroinflammation"},{"issue":"7","key":"5772_CR86","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1080\/15548627.2022.2046437","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wang J, Yang C (2022) Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease. Autophagy 18(7):1740\u20131742. https:\/\/doi.org\/10.1080\/15548627.2022.2046437","journal-title":"Autophagy"},{"issue":"7","key":"5772_CR87","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/1440-1681.13292","volume":"47","author":"Q Guo","year":"2020","unstructured":"Guo Q, He J, Zhang H, Yao L, Li H (2020) Oleanolic acid alleviates oxidative stress in Alzheimer\u2019s disease by regulating stanniocalcin-1 and uncoupling protein-2 signalling. Clin Exp Pharmacol Physiol 47(7):1263\u20131271. https:\/\/doi.org\/10.1111\/1440-1681.13292","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"5772_CR88","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1038\/s41598-018-27337-w","volume":"8","author":"T Wang","year":"2018","unstructured":"Wang T, Qiu RG, Yu M (2018) Predictive modeling of the progression of Alzheimer\u2019s disease with recurrent neural networks. Sci Rep 8(1):9161","journal-title":"Sci Rep"},{"issue":"4","key":"5772_CR89","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s12640-019-9999-2","volume":"35","author":"M Ahmad Rather","year":"2019","unstructured":"Ahmad Rather M, Justin-Thenmozhi A, Manivasagam T, Saravanababu C, Guillemin GJ, Essa MM (2019) Asiatic acid attenuated aluminum chloride-induced tau pathology, oxidative stress and apoptosis via AKT\/GSK-3\u03b2 signaling pathway in Wistar rats. Neurotox Res 35(4):955\u2013968. https:\/\/doi.org\/10.1007\/s12640-019-9999-2","journal-title":"Neurotox Res"},{"issue":"3","key":"5772_CR90","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s12640-018-9975-2","volume":"35","author":"S Sharma","year":"2019","unstructured":"Sharma S, Sharma N, Saini A, Nehru B (2019) Carbenoxolone reverses the amyloid beta 1\u201342 oligomer-induced oxidative damage and anxiety-related behavior in rats. Neurotox Res 35(3):654\u2013667. https:\/\/doi.org\/10.1007\/s12640-018-9975-2","journal-title":"Neurotox Res"},{"key":"5772_CR91","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neuroscience.2020.02.004","volume":"431","author":"S Sharma","year":"2020","unstructured":"Sharma S, Saini R, Sharma P, Saini A, Nehru B (2020) Maintenance of amyloid-beta homeostasis by carbenoxolone post A\u03b2-42 oligomer injection in rat brain. Neuroscience 431:86\u2013102. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.02.004","journal-title":"Neuroscience"},{"issue":"2","key":"5772_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102454","volume":"35","author":"HM Rasheed","year":"2023","unstructured":"Rasheed HM, Farooq U, Bashir K, Wahid F, Khan T, Khusro A, Gajdacs M, Alghamdi S, Alsaiari AA, Almehmadi M (2023) Isolation of oleanolic acid from Lavandula stoechas and its potent anticancer properties against MCF-7 cancer cells via induced apoptosis. Journal of King Saud University-Science 35(2):102454","journal-title":"Journal of King Saud University-Science"},{"issue":"6","key":"5772_CR93","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1590\/0004-282x20160065","volume":"74","author":"W Liang","year":"2016","unstructured":"Liang W, Zhao X, Feng J, Song F, Pan Y (2016) Ursolic acid attenuates beta-amyloid-induced memory impairment in mice. Arq Neuropsiquiatr 74(6):482\u2013488. https:\/\/doi.org\/10.1590\/0004-282x20160065","journal-title":"Arq Neuropsiquiatr"},{"key":"5772_CR94","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2021.12.004","volume":"88","author":"N Wang","year":"2022","unstructured":"Wang N, Wang E, Wang R, Muhammad F, Li T, Yue J, Zhou Y, Zhi D, Li H (2022) Ursolic acid ameliorates amyloid \u03b2-induced pathological symptoms in Caenorhabditis elegans by activating the proteasome. Neurotoxicology 88:231\u2013240. https:\/\/doi.org\/10.1016\/j.neuro.2021.12.004","journal-title":"Neurotoxicology"},{"key":"5772_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.steroids.2018.01.002","volume":"132","author":"TE Bert\u00e9","year":"2018","unstructured":"Bert\u00e9 TE, Dalmagro AP, Zimath PL, Gon\u00e7alves AE, Meyre-Silva C, B\u00fcrger C, Weber CJ, Dos Santos DA, Cechinel-Filho V, de Souza MM (2018) Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer\u2019s disease: effects against scopolamine and streptozotocin-induced cognitive dysfunctions. Steroids 132:5\u201311. https:\/\/doi.org\/10.1016\/j.steroids.2018.01.002","journal-title":"Steroids"},{"issue":"3","key":"5772_CR96","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12031-017-0989-7","volume":"63","author":"Z-H Kong","year":"2017","unstructured":"Kong Z-H, Chen X, Hua H-P, Liang L, Liu L-J (2017) The oral pretreatment of glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer\u2019s-related pathology via HMGB1 inhibition. J Mol Neurosci 63(3):385\u2013395. https:\/\/doi.org\/10.1007\/s12031-017-0989-7","journal-title":"J Mol Neurosci"},{"issue":"2","key":"5772_CR97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cns.12043","volume":"19","author":"H Zhao","year":"2013","unstructured":"Zhao H, Wang SL, Qian L, Jin JL, Li H, Xu Y, Zhu XL (2013) Diammonium glycyrrhizinate attenuates A\u03b2(1\u201342) -induced neuroinflammation and regulates MAPK and NF-\u03baB pathways in vitro and in vivo. CNS Neurosci Ther 19(2):117\u2013124. https:\/\/doi.org\/10.1111\/cns.12043","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"5772_CR98","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11481-015-9623-z","volume":"11","author":"H Badshah","year":"2016","unstructured":"Badshah H, Ali T, Shafiq-ur R, Faiz-ul A, Ullah F, Kim TH, Kim MO (2016) Protective effect of lupeol against lipopolysaccharide-induced neuroinflammation via the p38\/c-Jun N-terminal kinase pathway in the adult mouse brain. J Neuroimmune Pharmacol 11(1):48\u201360. https:\/\/doi.org\/10.1007\/s11481-015-9623-z","journal-title":"J Neuroimmune Pharmacol"},{"key":"5772_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108119","volume":"155","author":"Y Feng","year":"2025","unstructured":"Feng Y, Wang H, Hu Y, Zhang X, Miao X, Li Z, Jia J (2025) Hederagenin ameliorates ferroptosis-induced damage by regulating PPAR\u03b1\/Nrf2\/GPX4 signaling pathway in HT22 cells: an in vitro and in silico study. Bioorg Chem 155:108119. https:\/\/doi.org\/10.1016\/j.bioorg.2024.108119","journal-title":"Bioorg Chem"},{"issue":"2","key":"5772_CR100","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40199-018-0223-3","volume":"26","author":"WJ Hashmi","year":"2018","unstructured":"Hashmi WJ, Ismail H, Mehmood F, Mirza B (2018) Neuroprotective, antidiabetic and antioxidant effect of Hedera nepalensis and lupeol against STZ + AlCl(3) induced rats model. Daru 26(2):179\u2013190. https:\/\/doi.org\/10.1007\/s40199-018-0223-3","journal-title":"Daru"},{"key":"5772_CR101","doi-asserted-by":"publisher","unstructured":"Xie K, Wang H, Yao X, Lv J, Wang Q, Zhao Y, Yang S, Xu L et al (2025) Hederagenin reduces A\u03b2-induced oxidative damage, decreases A\u03b2 deposition, and promotes cell survival by the P13K\/Akt signaling pathway. J Leukoc Biol 117(2). https:\/\/doi.org\/10.1093\/jleuko\/qiae124","DOI":"10.1093\/jleuko\/qiae124"},{"issue":"50","key":"5772_CR102","doi-asserted-by":"publisher","first-page":"76135","DOI":"10.1007\/s11356-022-20611-5","volume":"29","author":"EA Mohamed","year":"2022","unstructured":"Mohamed EA, Ahmed HI, Zaky HS, Badr AM (2022) Boswellic acids ameliorate neurodegeneration induced by AlCl(3): the implication of Wnt\/\u03b2-catenin pathway. Environ Sci Pollut Res 29(50):76135\u201376143. https:\/\/doi.org\/10.1007\/s11356-022-20611-5","journal-title":"Environ Sci Pollut Res"},{"key":"5772_CR103","doi-asserted-by":"publisher","unstructured":"Apaza Ticona L, S\u00e1nchez S\u00e1nchez-Corral J, Zou Shi Y, Montoto Lozano N, Slowing Barillas K (2024) Pentacyclic triterpenes as bioactive compounds isolated from Mauritia flexuosa L. f. acting against the Alzheimer\u2019s disease. Nat Prod Res 1\u201310. https:\/\/doi.org\/10.1080\/14786419.2024.2412839","DOI":"10.1080\/14786419.2024.2412839"},{"issue":"1","key":"5772_CR104","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1080\/13880209.2022.2098344","volume":"60","author":"YJ Qu","year":"2022","unstructured":"Qu YJ, Ding MR, Gu C, Zhang LM, Zhen RR, Chen JF, Hu B, An HM (2022) Acteoside and ursolic acid synergistically protects H(2)O(2)-induced neurotrosis by regulation of AKT\/mTOR signalling: from network pharmacology to experimental validation. Pharm Biol 60(1):1751\u20131761. https:\/\/doi.org\/10.1080\/13880209.2022.2098344","journal-title":"Pharm Biol"},{"issue":"2","key":"5772_CR105","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3892\/etm.2016.4004","volume":"13","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li X, Li D, Luo M, Li Y, Song L, Jiang X (2017) Asiaticoside ameliorates \u03b2-amyloid-induced learning and memory deficits in rats by inhibiting mitochondrial apoptosis and reducing inflammatory factors. Exp Ther Med 13(2):413\u2013420. https:\/\/doi.org\/10.3892\/etm.2016.4004","journal-title":"Exp Ther Med"},{"key":"5772_CR106","doi-asserted-by":"publisher","unstructured":"Ahmad R, Khan A, Lee HJ, Ur Rehman I, Khan I, Alam SI, Kim MO (2020) Lupeol, a plant-derived triterpenoid, protects mice brains against A\u03b2-induced oxidative stress and neurodegeneration. Biomedicines 8(10). https:\/\/doi.org\/10.3390\/biomedicines8100380","DOI":"10.3390\/biomedicines8100380"},{"key":"5772_CR107","doi-asserted-by":"publisher","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JS, Zhang J, Yan R, Zheng X (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 5:388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","DOI":"10.1136\/bmj-2024-080952"},{"issue":"7","key":"5772_CR108","doi-asserted-by":"publisher","first-page":"e70659","DOI":"10.1002\/brb3.70659","volume":"15","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Wang H, He X, Fu R, Jin Z, Fu Q, Yu X, Li W, Zhu X, Zhang S (2025) The evolving global burden of young-onset Parkinson\u2019s disease (1990\u20132021): regional, gender, and age disparities in the context of rising incidence and declining mortality. Brain Behav 15(7):e70659","journal-title":"Brain Behav"},{"key":"5772_CR109","doi-asserted-by":"publisher","unstructured":"Pedroza P, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, Tsakalos G, Wimo A, Dieleman JL (2022) Global and regional spending on dementia care from 2000\u20132019 and expected future health spending scenarios from 2020\u20132050: an economic modelling exercise. EClinicalMedicine 13:45:101337. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101337","DOI":"10.1016\/j.eclinm.2022.101337"},{"issue":"1","key":"5772_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01532-w","volume":"21","author":"S Karout","year":"2021","unstructured":"Karout S, Soubra L, Rahme D, Karout L, Khojah HM, Itani R (2021) Prevalence, risk factors, and management practices of primary dysmenorrhea among young females. BMC Womens Health 21(1):392","journal-title":"BMC Womens Health"},{"key":"5772_CR111","doi-asserted-by":"crossref","unstructured":"Burch R, Rizzoli P, Loder E (2021) The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic\u2010specific estimates from government health surveys. Headache: J Head Face Pain 61(1):60\u201368","DOI":"10.1111\/head.14024"},{"issue":"6","key":"5772_CR112","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00702-024-02774-2","volume":"131","author":"H Matsui","year":"2024","unstructured":"Matsui H, Takahashi R (2024) Current trends in basic research on Parkinson\u2019s disease: from mitochondria, lysosome to \u03b1-synuclein. J Neural Transm 131(6):663\u2013674","journal-title":"J Neural Transm"},{"issue":"2","key":"5772_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurop.2024.100147","volume":"4","author":"P Salles","year":"2024","unstructured":"Salles P, Pizarro-Correa X, Chan\u00e1-Cuevas P (2024) Genetics of Parkinson\u2019s disease: recessive forms. Neurol Perspect 4(2):100147","journal-title":"Neurol Perspect"},{"key":"5772_CR114","unstructured":"Rosenberg RN, Pascual JM (eds) (2024) Rosenberg\u2019s molecular and genetic basis of neurological and psychiatric disease, 7th ed., vol 1\u20132. Elsevier"},{"issue":"3","key":"5772_CR115","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.pbb.2011.09.014","volume":"100","author":"CL Xu","year":"2012","unstructured":"Xu CL, Wang QZ, Sun LM, Li XM, Deng JM, Li LF, Zhang J, Xu R, et al. (2012) Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2\/Bax. Pharmacol Biochem Behav 100(3):413\u2013418. https:\/\/doi.org\/10.1016\/j.pbb.2011.09.014","journal-title":"Pharmacol Biochem Behav"},{"key":"5772_CR116","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jad.2022.08.026","volume":"316","author":"L Guo","year":"2022","unstructured":"Guo L, Qu B, Song C, Zhu S, Gong N, Sun J (2022) Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a\/PI3K\/Akt\/mTOR signaling pathways in differentiated rat pheochromocytoma cells. J Affect Disord 316:233\u2013242. https:\/\/doi.org\/10.1016\/j.jad.2022.08.026","journal-title":"J Affect Disord"},{"issue":"3","key":"5772_CR117","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s12011-023-03748-3","volume":"202","author":"S Salaramoli","year":"2024","unstructured":"Salaramoli S, Joshaghani HR, Hosseini M, Hashemy SI (2024) Therapeutic effects of selenium on alpha-synuclein accumulation in substantia Nigra pars compacta in a rat model of Parkinson\u2019s disease: behavioral and biochemical outcomes. Biol Trace Elem Res 202(3):1115\u20131125","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"5772_CR118","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s10072-023-07205-w","volume":"45","author":"CHF Camargo","year":"2024","unstructured":"Camargo CHF, Ferreira-Peruzzo SA, Ribas DIR, Franklin GL, Teive HA (2024) Imbalance and gait impairment in Parkinson\u2019s disease: discussing postural instability and ataxia. Neurol Sci 45(4):1377\u20131388","journal-title":"Neurol Sci"},{"key":"5772_CR119","doi-asserted-by":"publisher","unstructured":"Jalles C, Guerreiro D, Pona-Ferreira F, Sim\u00f5es RM, Reim\u00e3o S, Ferreira JJ (2025) Hypokinetic-rigid gait disorders with balance impairment-a walk through clinical and pathophysiological definitions. Parkinsonism Relat Disord 133:107339. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107339","DOI":"10.1016\/j.parkreldis.2025.107339"},{"issue":"8","key":"5772_CR120","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/14737175.2024.2372339","volume":"24","author":"L Angelini","year":"2024","unstructured":"Angelini L, Paparella G, Bologna M (2024) Distinguishing essential tremor from Parkinson\u2019s disease: clinical and experimental tools. Expert Rev Neurother 24(8):799\u2013814","journal-title":"Expert Rev Neurother"},{"issue":"23","key":"5772_CR121","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.3390\/cells11233736","volume":"11","author":"DK Kwon","year":"2022","unstructured":"Kwon DK, Kwatra M, Wang J, Ko HS (2022) Levodopa-induced dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies. Cells 11(23):3736","journal-title":"Cells"},{"issue":"6","key":"5772_CR122","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/14737175.2021.1851198","volume":"22","author":"A Powell","year":"2022","unstructured":"Powell A, Matar E, Lewis SJ (2022) Treating hallucinations in Parkinson\u2019s disease. Expert Rev Neurother 22(6):455\u2013468","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"5772_CR123","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","volume":"36","author":"SN Rai","year":"2019","unstructured":"Rai SN, Zahra W, Singh SS, Birla H, Keswani C, Dilnashin H, Rathore AS, Singh R, Singh RK, Singh SP (2019) Anti-inflammatory activity of ursolic acid in MPTP-induced Parkinsonian mouse model. Neurotox Res 36(3):452\u2013462. https:\/\/doi.org\/10.1007\/s12640-019-00038-6","journal-title":"Neurotox Res"},{"issue":"7","key":"5772_CR124","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/cjpp-2016-0158","volume":"95","author":"AM Ameen","year":"2017","unstructured":"Ameen AM, Elkazaz AY, Mohammad HMF, Barakat BM (2017) Anti-inflammatory and neuroprotective activity of boswellic acids in rotenone parkinsonian rats. Can J Physiol Pharmacol 95(7):819\u2013829. https:\/\/doi.org\/10.1139\/cjpp-2016-0158","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"5772_CR125","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12640-015-9579-z","volume":"29","author":"S Ojha","year":"2016","unstructured":"Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME (2016) Glycyrrhizic acid attenuates neuroinflammation and oxidative stress in rotenone model of Parkinson\u2019s disease. Neurotox Res 29(2):275\u2013287. https:\/\/doi.org\/10.1007\/s12640-015-9579-z","journal-title":"Neurotox Res"},{"key":"5772_CR126","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","volume":"91","author":"M Santoro","year":"2016","unstructured":"Santoro M, Maetzler W, Stathakos P, Martin HL, Hobert MA, Rattay TW, Gasser T, Forrester JV, Berg D, Tracey KJ, Riedel G, Teismann P (2016) In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson\u2019s disease which can be attenuated by glycyrrhizin. Neurobiol Dis 91:59\u201368. https:\/\/doi.org\/10.1016\/j.nbd.2016.02.018","journal-title":"Neurobiol Dis"},{"issue":"4","key":"5772_CR127","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1039\/c6fo00041j","volume":"7","author":"PC Chao","year":"2016","unstructured":"Chao PC, Lee HL, Yin MC (2016) Asiatic acid attenuated apoptotic and inflammatory stress in the striatum of MPTP-treated mice. Food Funct 7(4):1999\u20132005. https:\/\/doi.org\/10.1039\/c6fo00041j","journal-title":"Food Funct"},{"issue":"6","key":"5772_CR128","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/1028415x.2015.1135559","volume":"20","author":"J Nataraj","year":"2017","unstructured":"Nataraj J, Manivasagam T, Justin Thenmozhi A, Essa MM (2017) Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells. Nutr Neurosci 20(6):351\u2013359. https:\/\/doi.org\/10.1080\/1028415x.2015.1135559","journal-title":"Nutr Neurosci"},{"issue":"2","key":"5772_CR129","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11011-022-00962-1","volume":"38","author":"M Abrishamdar","year":"2023","unstructured":"Abrishamdar M, Farbood Y, Sarkaki A, Rashno M, Badavi M (2023) Evaluation of betulinic acid effects on pain, memory, anxiety, catalepsy, and oxidative stress in animal model of Parkinson\u2019s disease. Metab Brain Dis 38(2):467\u2013482. https:\/\/doi.org\/10.1007\/s11011-022-00962-1","journal-title":"Metab Brain Dis"},{"key":"5772_CR130","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.freeradbiomed.2025.04.013","volume":"233","author":"SK Pandey","year":"2025","unstructured":"Pandey SK, Nanda A, Gautam AS, Singh RK (2025) Betulinic acid protects against lipopolysaccharide and ferrous sulfate-induced oxidative stress, ferroptosis, apoptosis, and neuroinflammation signaling relevant to Parkinson\u2019s disease. Free Radic Biol Med 233:340\u2013354. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.04.013","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"5772_CR131","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41401-022-00988-2","volume":"44","author":"Y Bang","year":"2023","unstructured":"Bang Y, Kwon Y, Kim M, Moon SH, Jung K, Choi HJ (2023) Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson\u2019s disease mice model. Acta Pharmacol Sin 44(4):752\u2013765. https:\/\/doi.org\/10.1038\/s41401-022-00988-2","journal-title":"Acta Pharmacol Sin"},{"key":"5772_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"SN Rai","year":"2016","unstructured":"Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 71:41\u201349. https:\/\/doi.org\/10.1016\/j.jchemneu.2015.12.002","journal-title":"J Chem Neuroanat"},{"issue":"7","key":"5772_CR133","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1871527319666200812224457","volume":"19","author":"W Zahra","year":"2020","unstructured":"Zahra W, Rai SN, Birla H, Singh SS, Rathore AS, Dilnashin H, Singh R, Keswani C, Singh RK, Singh SP (2020) Neuroprotection of rotenone-induced parkinsonism by ursolic acid in PD mouse model. CNS Neurol Disord Drug Targets 19(7):527\u2013540. https:\/\/doi.org\/10.2174\/1871527319666200812224457","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"5772_CR134","doi-asserted-by":"publisher","first-page":"125197","DOI":"10.1016\/j.ijpharm.2025.125197","volume":"670","author":"HA Nematalla","year":"2025","unstructured":"Nematalla HA, Elharoun M, Bargash SN, Abd-Alhaseeb MM, Sharafeldin HA, Zewail M, Abbas H, Elsheikh MA (2025) Novel nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson\u2019s symptoms management: in vitro and in vivo evaluation in a rotenone-induced rat model. Int J Pharm 670:125197. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125197","journal-title":"Int J Pharm"},{"key":"5772_CR135","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2013.11.016","volume":"79","author":"P Thakur","year":"2014","unstructured":"Thakur P, Nehru B (2014) Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson\u2019s disease in a rotenone-based model. Neuropharmacology 79:190\u2013200. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.016","journal-title":"Neuropharmacology"},{"issue":"1","key":"5772_CR136","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11064-013-1193-y","volume":"39","author":"BS Choi","year":"2014","unstructured":"Choi BS, Kim H, Lee HJ, Sapkota K, Park SE, Kim S, Kim SJ (2014) Celastrol from \u201cThunder God Vine\u201d protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson\u2019s disease. Neurochem Res 39(1):84\u201396. https:\/\/doi.org\/10.1007\/s11064-013-1193-y","journal-title":"Neurochem Res"},{"key":"5772_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102134","volume":"47","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R (2021) The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease. Redox Biol 47:102134. https:\/\/doi.org\/10.1016\/j.redox.2021.102134","journal-title":"Redox Biol"},{"issue":"6","key":"5772_CR138","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12272-025-01550-4","volume":"48","author":"HB Yang","year":"2025","unstructured":"Yang HB, Lee CH, Nhung NT, Hung SY (2025) Oleanolic acid activates the JNK-Sp1-DJ-1 axis to promote mitophagy-mediated neuroprotection in dopaminergic neurons for Parkinson\u2019s disease treatment. Arch Pharm Res 48(6):528\u2013548. https:\/\/doi.org\/10.1007\/s12272-025-01550-4","journal-title":"Arch Pharm Res"},{"key":"5772_CR139","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.intimp.2019.02.055","volume":"70","author":"MS Oliveira-Junior","year":"2019","unstructured":"Oliveira-Junior MS, Pereira EP, de Amorim VCM, Reis LTC, do Nascimento RP da Silva VDA Costa SL (2019) Lupeol inhibits LPS-induced neuroinflammation in cerebellar cultures and induces neuroprotection associated to the modulation of astrocyte response and expression of neurotrophic and inflammatory factors. Int Immunopharmacol 70:302\u2013312. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.055","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5772_CR140","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12031-014-0303-x","volume":"55","author":"GP Selvakumar","year":"2015","unstructured":"Selvakumar GP, Manivasagam T, Rekha KR, Jayaraj RL, Elangovan N (2015) Escin, a novel triterpene, mitigates chronic MPTP\/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis. J Mol Neurosci 55(1):184\u2013197. https:\/\/doi.org\/10.1007\/s12031-014-0303-x","journal-title":"J Mol Neurosci"},{"key":"5772_CR141","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2014.03.010","volume":"1585","author":"GP Selvakumar","year":"2014","unstructured":"Selvakumar GP, Janakiraman U, Essa MM, Justin Thenmozhi A, Manivasagam T (2014) Escin attenuates behavioral impairments, oxidative stress and inflammation in a chronic MPTP\/probenecid mouse model of Parkinson\u2019s disease. Brain Res 1585:23\u201336. https:\/\/doi.org\/10.1016\/j.brainres.2014.03.010","journal-title":"Brain Res"},{"key":"5772_CR142","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.freeradbiomed.2024.09.030","volume":"224","author":"X Li","year":"2024","unstructured":"Li X, Hu M, Zhou X, Yu L, Qin D, Wu J, Deng L, Huang L, Ren F, Liao B, Wu A, Fan D (2024) Hederagenin inhibits mitochondrial damage in Parkinson\u2019s disease via mitophagy induction. Free Radic Biol Med 224:740\u2013756. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.09.030","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"5772_CR143","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/17460441.2023.2201493","volume":"18","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Jamwal S, Kumar P (2023) Animal models of Huntington\u2019s disease and their applicability to novel drug discovery and development. Expert Opin Drug Discov 18(5):527\u2013538","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"5772_CR144","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","volume":"48","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Yedke NG, Rahi V, Singh S, Kumar S, Arora A, Chandolia P, Kaur P et al (2023) An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a huntington\u2019s disease model and its relevance to drug discovery and development. Neurochem Res 48(6):1631\u20131647","journal-title":"Neurochem Res"},{"issue":"7","key":"5772_CR145","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WM, Flower MD, Scahill RI, Wild EJ, Mu\u00f1oz-Sanjuan I, Sampaio C et al (2022) Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol 21(7):645\u2013658","journal-title":"Lancet Neurol"},{"issue":"12","key":"5772_CR146","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/mds.29228","volume":"37","author":"A Medina","year":"2022","unstructured":"Medina A, Mahjoub Y, Shaver L, Pringsheim T (2022) Prevalence and incidence of Huntington\u2019s disease: an updated systematic review and meta-analysis. Mov Disord 37(12):2327\u20132335","journal-title":"Mov Disord"},{"issue":"6","key":"5772_CR147","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s12272-024-01499-w","volume":"47","author":"A Shafie","year":"2024","unstructured":"Shafie A, Ashour AA, Anwar S, Anjum F, Hassan MI (2024) Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington\u2019s disease. Arch Pharm Res 47(6):571\u2013595","journal-title":"Arch Pharm Res"},{"issue":"1","key":"5772_CR148","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10048-025-00801-2","volume":"26","author":"OK Kunwar","year":"2025","unstructured":"Kunwar OK, Singh S (2025) Neuroinflammation and neurodegeneration in Huntington\u2019s disease: genetic hallmarks, role of metals and organophosphates. Neurogenetics 26(1):21","journal-title":"Neurogenetics"},{"key":"5772_CR149","doi-asserted-by":"publisher","first-page":"1088124","DOI":"10.3389\/fimmu.2022.1088124","volume":"13","author":"Q Jia","year":"2022","unstructured":"Jia Q, Li S, Li X-J, Yin P (2022) Neuroinflammation in Huntington\u2019s disease: from animal models to clinical therapeutics. Front Immunol 13:1088124","journal-title":"Front Immunol"},{"issue":"4","key":"5772_CR150","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s43440-024-00619-z","volume":"76","author":"S Upadhayay","year":"2024","unstructured":"Upadhayay S, Kumar P (2024) Mitochondrial targeted antioxidants as potential therapy for Huntington\u2019s disease. Pharmacol Rep 76(4):693\u2013713","journal-title":"Pharmacol Rep"},{"key":"5772_CR151","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","volume":"71","author":"T Alqahtani","year":"2023","unstructured":"Alqahtani T, Deore SL, Kide AA, Shende BA, Sharma R, Chakole RD, Nemade LS, Kale NK et al (2023) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review. Mitochondrion 71:83\u201392","journal-title":"Mitochondrion"},{"issue":"11","key":"5772_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142901","volume":"10","author":"L Qi","year":"2015","unstructured":"Qi L, Sun X, Li FE, Zhu BS, Braun FK, Liu ZQ, Tang JL, Wu C et al (2015) HMGB1 promotes mitochondrial dysfunction-triggered striatal neurodegeneration via autophagy and apoptosis activation. PLoS ONE 10(11):e0142901. https:\/\/doi.org\/10.1371\/journal.pone.0142901","journal-title":"PLoS ONE"},{"issue":"4","key":"5772_CR153","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1471-4159.2005.03253.x","volume":"94","author":"C Cleren","year":"2005","unstructured":"Cleren C, Calingasan NY, Chen J, Beal MF (2005) Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J Neurochem 94(4):995\u20131004. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03253.x","journal-title":"J Neurochem"},{"key":"5772_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.116910","volume":"485","author":"T Han","year":"2024","unstructured":"Han T, Sun Z, Zhang H, Zhao Y, Jiao A, Gao Q (2024) Ursolic acid alleviates meiotic abnormalities induced by 3-nitropropionic acid in mouse oocytes. Toxicol Appl Pharmacol 485:116910. https:\/\/doi.org\/10.1016\/j.taap.2024.116910","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"5772_CR155","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11011-017-0143-9","volume":"33","author":"C Loganathan","year":"2018","unstructured":"Loganathan C, Thayumanavan P (2018) Asiatic acid prevents the quinolinic acid-induced oxidative stress and cognitive impairment. Metab Brain Dis 33(1):151\u2013159. https:\/\/doi.org\/10.1007\/s11011-017-0143-9","journal-title":"Metab Brain Dis"},{"issue":"1","key":"5772_CR156","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of multiple sclerosis: global, regional, national and sub-national-level estimates and future projections. J Epidemiol Glob Health 15(1):21","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"5772_CR157","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12883-022-02700-7","volume":"22","author":"Z Hosseini","year":"2022","unstructured":"Hosseini Z, Homayuni A, Etemadifar M (2022) Barriers to quality of life in patients with multiple sclerosis: a qualitative study. BMC Neurol 22(1):174","journal-title":"BMC Neurol"},{"issue":"3","key":"5772_CR158","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11195-024-09864-9","volume":"42","author":"F Sohrabi","year":"2024","unstructured":"Sohrabi F, Tirgari B, Alizadeh S, Salehi S (2024) The effect of sexual counseling based on the PLISSIT model on family functioning and sexual quality of life of women with multiple sclerosis. Sex Disabil 42(3):553\u2013566","journal-title":"Sex Disabil"},{"issue":"3","key":"5772_CR159","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jphs.2020.08.002","volume":"144","author":"S Yamamoto","year":"2020","unstructured":"Yamamoto S, Sakemoto C, Iwasa K, Maruyama K, Shimizu K, Yoshikawa K (2020) Ursolic acid treatment suppresses cuprizone-induced demyelination and motor dysfunction via upregulation of IGF-1. J Pharmacol Sci 144(3):119\u2013122. https:\/\/doi.org\/10.1016\/j.jphs.2020.08.002","journal-title":"J Pharmacol Sci"},{"issue":"10","key":"5772_CR160","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s12031-022-02059-x","volume":"72","author":"F Honarvar","year":"2022","unstructured":"Honarvar F, Hojati V, Zare L, Bakhtiari N, Javan M (2022) Ursolic acid enhances myelin repair in adult mice brains and stimulates exhausted oligodendrocyte progenitors to remyelinate. J Mol Neurosci 72(10):2081\u20132093. https:\/\/doi.org\/10.1007\/s12031-022-02059-x","journal-title":"J Mol Neurosci"},{"issue":"16","key":"5772_CR161","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1073\/pnas.2000208117","volume":"117","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li X, Ciric B, Curtis MT, Chen WJ, Rostami A, Zhang GX (2020) A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Proc Natl Acad Sci U S A 117(16):9082\u20139093. https:\/\/doi.org\/10.1073\/pnas.2000208117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5772_CR162","doi-asserted-by":"publisher","unstructured":"Scherrer EC, Ramos KA, Valadares YM, Soares IGM, Carli AP, F SS, Silva JG, Alvarenga DG et al (2025) Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation. Metab Brain Dis 40(4):166. https:\/\/doi.org\/10.1007\/s11011-025-01591-0","DOI":"10.1007\/s11011-025-01591-0"},{"key":"5772_CR163","doi-asserted-by":"publisher","unstructured":"Asmis R, Medrano MT, Chase Huizar C, Griffith WP, Forsthuber TG (2024) Dietary supplementation with 23-hydroxy ursolic acid reduces the severity and incidence of acute experimental autoimmune encephalomyelitis (EAE) in a murine model of multiple sclerosis. Nutrients 16(3). https:\/\/doi.org\/10.3390\/nu16030348","DOI":"10.3390\/nu16030348"},{"issue":"4","key":"5772_CR164","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00011-019-01219-x","volume":"68","author":"SH Venkatesha","year":"2019","unstructured":"Venkatesha SH, Moudgil KD (2019) Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK\/SGK1-regulated mediators of autoimmune pathology. Inflamm Res 68(4):285\u2013296. https:\/\/doi.org\/10.1007\/s00011-019-01219-x","journal-title":"Inflamm Res"},{"issue":"3","key":"5772_CR165","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s11481-015-9598-9","volume":"10","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cao L, Xu LM, Cao FF, Peng B, Zhang X, Shen YF, Uzan G et al (2015) Celastrol ameliorates EAE induction by suppressing pathogenic T cell responses in the peripheral and central nervous systems. J Neuroimmune Pharmacol 10(3):506\u2013516. https:\/\/doi.org\/10.1007\/s11481-015-9598-9","journal-title":"J Neuroimmune Pharmacol"},{"key":"5772_CR166","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2014.09.001","volume":"742","author":"AA Abdin","year":"2014","unstructured":"Abdin AA, Hasby EA (2014) Modulatory effect of celastrol on Th1\/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats. Eur J Pharmacol 742:102\u2013112. https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.001","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5772_CR167","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1039\/c9fo01459d","volume":"11","author":"J Tian","year":"2020","unstructured":"Tian J, Li X, Zhao L, Shen P, Wang Z, Zhu L, Li C, Su C et al (2020) Glycyrrhizic acid promotes neural repair by directly driving functional remyelination. Food Funct 11(1):992\u20131005. https:\/\/doi.org\/10.1039\/c9fo01459d","journal-title":"Food Funct"},{"issue":"12","key":"5772_CR168","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1089\/dna.2018.4444","volume":"37","author":"J Li","year":"2018","unstructured":"Li J, Shi J, Sun Y, Zheng F (2018) Glycyrrhizin, a potential drug for autoimmune encephalomyelitis by inhibiting high-mobility group box 1. DNA Cell Biol 37(12):941\u2013946. https:\/\/doi.org\/10.1089\/dna.2018.4444","journal-title":"DNA Cell Biol"},{"issue":"4","key":"5772_CR169","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/08923973.2018.1490318","volume":"40","author":"S Kamisli","year":"2018","unstructured":"Kamisli S, Ciftci O, Taslidere A, Basak Turkmen N, Ozcan C (2018) The beneficial effects of 18\u03b2-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mouse model. Immunopharmacol Immunotoxicol 40(4):344\u2013352. https:\/\/doi.org\/10.1080\/08923973.2018.1490318","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"5772_CR170","doi-asserted-by":"publisher","first-page":"13713","DOI":"10.1038\/srep13713","volume":"5","author":"J Zhou","year":"2015","unstructured":"Zhou J, Cai W, Jin M, Xu J, Wang Y, Xiao Y, Hao L, Wang B et al (2015) 18\u03b2-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination. Sci Rep 5:13713. https:\/\/doi.org\/10.1038\/srep13713","journal-title":"Sci Rep"},{"issue":"1","key":"5772_CR171","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000505333","volume":"27","author":"Y Chen","year":"2020","unstructured":"Chen Y, Hu Z, Li R, Qiu W, Hu X, Zhou Z (2020) The effects of carbenoxolone against experimental autoimmune encephalomyelitis in a mouse model. NeuroImmunoModulation 27(1):19\u201327. https:\/\/doi.org\/10.1159\/000505333","journal-title":"NeuroImmunoModulation"},{"key":"5772_CR172","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2011.09.012","volume":"240","author":"L Endong","year":"2011","unstructured":"Endong L, Shijie J, Sonobe Y, Di M, Hua L, Kawanokuchi J, Mizuno T, Suzumura A (2011) The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells. J Neuroimmunol 240:58\u201364. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.09.012","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5772_CR173","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12974-020-02042-6","volume":"17","author":"B Gutierrez","year":"2020","unstructured":"Gutierrez B, Gallardo I, Ruiz L, Alvarez Y, Cachofeiro V, Margolles A, Hernandez M, Nieto ML (2020) Oleanolic acid ameliorates intestinal alterations associated with EAE. J Neuroinflammation 17(1):363. https:\/\/doi.org\/10.1186\/s12974-020-02042-6","journal-title":"J Neuroinflammation"},{"issue":"2","key":"5772_CR174","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bcp.2009.08.002","volume":"79","author":"R Mart\u00edn","year":"2010","unstructured":"Mart\u00edn R, Carvalho-Tavares J, Hern\u00e1ndez M, Arn\u00e9s M, Ruiz-Guti\u00e9rrez V, Nieto ML (2010) Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Biochem Pharmacol 79(2):198\u2013208. https:\/\/doi.org\/10.1016\/j.bcp.2009.08.002","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"5772_CR175","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/iub.2863","volume":"76","author":"D Guan","year":"2024","unstructured":"Guan D, Li Y, Zhao X, Wang K, Guo Y, Dong N, Cui Y, Gao Y et al (2024) Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation. IUBMB Life 76(10):845\u2013857. https:\/\/doi.org\/10.1002\/iub.2863","journal-title":"IUBMB Life"},{"issue":"3","key":"5772_CR176","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/aps.2012.181","volume":"34","author":"J Bla\u017eevski","year":"2013","unstructured":"Bla\u017eevski J, Petkovi\u0107 F, Mom\u010dilovi\u0107 M, Paschke R, Kalu\u0111erovi\u0107 GN, Mostarica Stojkovi\u0107 M, Miljkovi\u0107 D (2013) Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro. Acta Pharmacol Sin 34(3):424\u2013431","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"5772_CR177","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1124\/mol.116.107136","volume":"91","author":"J Li","year":"2017","unstructured":"Li J, Jing J, Bai Y, Li Z, Xing R, Tan B, Ma X, Qiu W-W et al (2017) SH479, a betulinic acid derivative, ameliorates experimental autoimmune encephalomyelitis by regulating the T helper 17\/regulatory T cell balance. Mol Pharmacol 91(5):464\u2013474","journal-title":"Mol Pharmacol"},{"key":"5772_CR178","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.biopha.2018.02.098","volume":"101","author":"VR Askari","year":"2018","unstructured":"Askari VR, Fereydouni N, Rahimi VB, Askari N, Sahebkar AH, Rahmanian-Devin P, Samzadeh-Kermani A (2018) \u03b2-amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide\/interferon-\u03b3 and regulates M\u03c61\/M\u03c62 balances. Biomed Pharmacother 101:438\u2013446","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5772_CR179","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/srep00201","volume":"1","author":"TK Pareek","year":"2011","unstructured":"Pareek TK, Belkadi A, Kesavapany S, Zaremba A, Loh SL, Bai L, Cohen ML, Meyer C et al (2011) Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis. Sci Rep 1(1):201","journal-title":"Sci Rep"},{"issue":"1","key":"5772_CR180","doi-asserted-by":"publisher","first-page":"9886","DOI":"10.1038\/s41598-017-06907-4","volume":"7","author":"H-J Wei","year":"2017","unstructured":"Wei H-J, Pareek TK, Liu Q, Letterio JJ (2017) A unique tolerizing dendritic cell phenotype induced by the synthetic triterpenoid CDDO-DFPA (RTA-408) is protective against EAE. Sci Rep 7(1):9886","journal-title":"Sci Rep"},{"issue":"11","key":"5772_CR181","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021) Nrf2\/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem Res 46(11):2867\u20132884. https:\/\/doi.org\/10.1007\/s11064-021-03366-2","journal-title":"Neurochem Res"},{"key":"5772_CR182","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.toxrep.2022.04.023","volume":"9","author":"R Sahu","year":"2022","unstructured":"Sahu R, Mehan S, Kumar S, Prajapati A, Alshammari A, Alharbi M, Assiri MA, Narula AS (2022) Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol Rep 9:977","journal-title":"Toxicol Rep"},{"issue":"3","key":"5772_CR183","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ (2023) Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov 22(3):185\u2013212","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"5772_CR184","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.clinph.2020.04.161","volume":"131","author":"E Fileccia","year":"2020","unstructured":"Fileccia E, De Pasqua S, Rizzo G, Di Stasi V, Vacchiano V, Avoni P, Bartolomei I, Pastorelli F et al (2020) Denervation findings on EMG in amyotrophic lateral sclerosis and correlation with prognostic milestones: data from a retrospective study. Clin Neurophysiol 131(8):2017\u20132022","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"5772_CR185","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/awab404","volume":"145","author":"M Benatar","year":"2022","unstructured":"Benatar M, Wuu J, McHutchison C, Postuma RB, Boeve BF, Petersen R, Ross CA, Rosen H et al (2022) Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145(1):27\u201344","journal-title":"Brain"},{"issue":"9","key":"5772_CR186","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s10072-024-07508-6","volume":"45","author":"GB Kubat","year":"2024","unstructured":"Kubat GB, Picone P (2024) Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches. Neurol Sci 45(9):4121\u20134131","journal-title":"Neurol Sci"},{"issue":"6","key":"5772_CR187","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","volume":"101","author":"C Wolfson","year":"2023","unstructured":"Wolfson C, Gauvin DE, Ishola F, Oskoui M (2023) Global prevalence and incidence of amyotrophic lateral sclerosis: a systematic review. Neurology 101(6):e613\u2013e623","journal-title":"Neurology"},{"issue":"7\u20138","key":"5772_CR188","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/21678421.2023.2245858","volume":"24","author":"P Mehta","year":"2023","unstructured":"Mehta P, Raymond J, Zhang Y, Punjani R, Han M, Larson T, Muravov O, Lyles RH et al (2023) Prevalence of amyotrophic lateral sclerosis in the United States, 2018. Amyotroph Lateral Scler Frontotemporal Degener 24(7\u20138):702\u2013708","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3\u20134","key":"5772_CR189","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21678421.2024.2447919","volume":"26","author":"P Mehta","year":"2025","unstructured":"Mehta P, Raymond J, Nair T, Han M, Berry J, Punjani R, Larson T, Mohidul S et al (2025) Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry. Amyotroph Lateral Scler Frontotemporal Degener 26(3\u20134):290\u2013295","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"6","key":"5772_CR190","doi-asserted-by":"publisher","first-page":"e13078","DOI":"10.1111\/bpa.13078","volume":"32","author":"S Salvany","year":"2022","unstructured":"Salvany S, Casanovas A, Piedrafita L, Gras S, Calder\u00f3 J, Esquerda JE (2022) Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol 32(6):e13078","journal-title":"Brain Pathol"},{"issue":"6","key":"5772_CR191","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00018-023-04797-6","volume":"80","author":"C Lefebvre-Omar","year":"2023","unstructured":"Lefebvre-Omar C, Liu E, Dalle C, d\u2019Incamps BL, Bigou S, Daube C, Karpf L, Davenne M et al (2023) Neurofilament accumulations in amyotrophic lateral sclerosis patients\u2019 motor neurons impair axonal initial segment integrity. Cell Mol Life Sci 80(6):150","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"5772_CR192","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/brain\/awab285","volume":"145","author":"N Riva","year":"2022","unstructured":"Riva N, Gentile F, Cerri F, Gallia F, Podini P, Dina G, Falzone YM, Fazio R et al (2022) Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain 145(1):276\u2013284","journal-title":"Brain"},{"key":"5772_CR193","doi-asserted-by":"publisher","first-page":"136107","DOI":"10.1016\/j.neulet.2021.136107","volume":"761","author":"M Saljuqi","year":"2021","unstructured":"Saljuqi M, Ghaderyan P (2021) A novel method based on matching pursuit decomposition of gait signals for Parkinson\u2019s disease, amyotrophic lateral sclerosis and Huntington\u2019s disease detection. Neurosci Lett 761:136107","journal-title":"Neurosci Lett"},{"issue":"10360","key":"5772_CR194","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363\u20131380","journal-title":"Lancet"},{"issue":"7\u20138","key":"5772_CR195","doi-asserted-by":"publisher","first-page":"151179","DOI":"10.1016\/j.ejcb.2021.151179","volume":"100","author":"R Sahu","year":"2021","unstructured":"Sahu R, Upadhayay S, Mehan S (2021) Inhibition of extracellular regulated kinase (ERK)-1\/2 signaling pathway in the prevention of ALS: target inhibitors and influences on neurological dysfunctions. Eur J Cell Biol 100(7\u20138):151179","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"5772_CR196","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000090364","volume":"2","author":"M Kiaei","year":"2005","unstructured":"Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2(5):246\u2013254. https:\/\/doi.org\/10.1159\/000090364","journal-title":"Neurodegener Dis"},{"issue":"1","key":"5772_CR197","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2011.03.027","volume":"51","author":"A Neymotin","year":"2011","unstructured":"Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R et al (2011) Neuroprotective effect of Nrf2\/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic Biol Med 51(1):88\u201396. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.03.027","journal-title":"Free Radic Biol Med"},{"key":"5772_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105876","volume":"180","author":"R Sharma","year":"2024","unstructured":"Sharma R, Mehan S, Khan Z, Das Gupta G, Narula AS (2024) Therapeutic potential of oleanolic acid in modulation of PI3K\/Akt\/mTOR\/STAT-3\/GSK-3\u03b2 signaling pathways and neuroprotection against methylmercury-induced neurodegeneration. Neurochem Int 180:105876. https:\/\/doi.org\/10.1016\/j.neuint.2024.105876","journal-title":"Neurochem Int"},{"issue":"6","key":"5772_CR199","first-page":"751","volume":"69","author":"YH Li","year":"2017","unstructured":"Li YH, Liu SB, Zhang HY, Zhou FH, Liu YX, Lu Q, Yang L (2017) Antioxidant effects of celastrol against hydrogen peroxide-induced oxidative stress in the cell model of amyotrophic lateral sclerosis. Sheng Li Xue Bao 69(6):751\u2013758","journal-title":"Sheng Li Xue Bao"},{"issue":"2","key":"5772_CR200","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1474-4422(20)30396-3","volume":"20","author":"T Proix","year":"2021","unstructured":"Proix T, Truccolo W, Leguia MG, Tcheng TK, King-Stephens D, Rao VR, Baud MO (2021) Forecasting seizure risk in adults with focal epilepsy: a development and validation study. Lancet Neurol 20(2):127\u2013135","journal-title":"Lancet Neurol"},{"issue":"4","key":"5772_CR201","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ana.26443","volume":"92","author":"M Pease","year":"2022","unstructured":"Pease M, Gonzalez-Martinez J, Puccio A, Nwachuku E, Castellano JF, Okonkwo DO, Elmer J (2022) Risk factors and incidence of epilepsy after severe traumatic brain injury. Ann Neurol 92(4):663\u2013669","journal-title":"Ann Neurol"},{"issue":"11","key":"5772_CR202","doi-asserted-by":"publisher","first-page":"e209450","DOI":"10.1212\/WNL.0000000000209450","volume":"102","author":"T Tanaka","year":"2024","unstructured":"Tanaka T, Ihara M, Fukuma K, Mishra NK, Koepp MJ, Guekht A, Ikeda A (2024) Pathophysiology, diagnosis, prognosis, and prevention of poststroke epilepsy: clinical and research implications. Neurology 102(11):e209450","journal-title":"Neurology"},{"issue":"3","key":"5772_CR203","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/epi.17494","volume":"64","author":"E Beghi","year":"2023","unstructured":"Beghi E, Giussani G, Costa C, DiFrancesco JC, Dhakar M, Leppik I, Kwan P, Akamatsu N et al (2023) The epidemiology of epilepsy in older adults: a narrative review by the ILAE task force on epilepsy in the elderly. Epilepsia 64(3):586\u2013601","journal-title":"Epilepsia"},{"issue":"21","key":"5772_CR204","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13216396","volume":"13","author":"S Di Noia","year":"2024","unstructured":"Di Noia S, Bonezzi L, Accorinti I, Bartolini E (2024) Diagnosis and classification of pediatric epilepsy in Sub-Saharan Africa: a comprehensive review. J Clin Med 13(21):6396","journal-title":"J Clin Med"},{"issue":"3","key":"5772_CR205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012059","volume":"18","author":"L-J Amaral","year":"2024","unstructured":"Amaral L-J, Jada SR, Ndjanfa AK, Carter JY, Abd-Elfarag G, Okaro S, Logora MY, Bol YY et al (2024) Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study. PLoS Negl Trop Dis 18(3):e0012059","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"5772_CR206","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s40120-025-00710-4","volume":"14","author":"C Zhong","year":"2025","unstructured":"Zhong C, Yang K, Wang N, Yang L, Yang Z, Xu L, Wang J, Zhang L (2025) Advancements in surgical therapies for drug-resistant epilepsy: a paradigm shift towards precision care. Neurol Ther 14(2):467\u2013490","journal-title":"Neurol Ther"},{"issue":"9","key":"5772_CR207","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/cells12091233","volume":"12","author":"W L\u00f6scher","year":"2023","unstructured":"L\u00f6scher W, White HS (2023) Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments. Cells 12(9):1233","journal-title":"Cells"},{"issue":"9","key":"5772_CR208","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s40263-023-01025-4","volume":"37","author":"E Perucca","year":"2023","unstructured":"Perucca E, White HS, Bialer M (2023) New GABA-targeting therapies for the treatment of seizures and epilepsy: II. treatments in clinical development. CNS Drugs 37(9):781\u2013795","journal-title":"CNS Drugs"},{"issue":"1","key":"5772_CR209","doi-asserted-by":"publisher","first-page":"21771","DOI":"10.1038\/s41598-024-72249-7","volume":"14","author":"SR Sheikh","year":"2024","unstructured":"Sheikh SR, McKee ZA, Ghosn S, Jeong K-S, Kattan M, Burgess RC, Jehi L, Saab CY (2024) Machine learning algorithm for predicting seizure control after temporal lobe resection using peri-ictal electroencephalography. Sci Rep 14(1):21771","journal-title":"Sci Rep"},{"key":"5772_CR210","doi-asserted-by":"publisher","first-page":"107516","DOI":"10.1016\/j.eplepsyres.2025.107516","volume":"210","author":"ME Speakes","year":"2025","unstructured":"Speakes ME, Reznik-Schaefer K, Al-Ramadhani R, Fernandez LD, Hect JL, Abel TJ, Welch WP (2025) Treatment of pediatric drug-resistant generalized epilepsy with responsive neurostimulation of the centromedian nucleus of the thalamus: a case series of seven patients. Epilepsy Res 210:107516","journal-title":"Epilepsy Res"},{"issue":"3","key":"5772_CR211","doi-asserted-by":"publisher","first-page":"e00308","DOI":"10.1016\/j.neurot.2023.e00308","volume":"21","author":"FV Gouveia","year":"2024","unstructured":"Gouveia FV, Warsi NM, Suresh H, Matin R, Ibrahim GM (2024) Neurostimulation treatments for epilepsy: deep brain stimulation, responsive neurostimulation and vagus nerve stimulation. Neurotherapeutics 21(3):e00308","journal-title":"Neurotherapeutics"},{"issue":"4","key":"5772_CR212","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/epi.17524","volume":"64","author":"Z Haneef","year":"2023","unstructured":"Haneef Z, Skrehot HC (2023) Neurostimulation in generalized epilepsy: a systematic review and meta-analysis. Epilepsia 64(4):811\u2013820","journal-title":"Epilepsia"},{"key":"5772_CR213","doi-asserted-by":"publisher","first-page":"109182","DOI":"10.1016\/j.yebeh.2023.109182","volume":"142","author":"HC Skrehot","year":"2023","unstructured":"Skrehot HC, Englot DJ, Haneef Z (2023) Neuro-stimulation in focal epilepsy: a systematic review and meta-analysis. Epilepsy Behav 142:109182","journal-title":"Epilepsy Behav"},{"key":"5772_CR214","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e120686","volume":"71","author":"I Vaneva","year":"2024","unstructured":"Vaneva I, Ibryam I, Kuzmanova R (2024) Intake of anticonvulsant drugs by women with epilepsy during pregnancy and breastfeeding: advantages and disadvantages. Pharmacia 71:1\u20138","journal-title":"Pharmacia"},{"issue":"5","key":"5772_CR215","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/epd2.20093","volume":"25","author":"T Tomson","year":"2023","unstructured":"Tomson T, Zelano J, Dang YL, Perucca P (2023) The pharmacological treatment of epilepsy in adults. Epileptic Disord 25(5):649\u2013669","journal-title":"Epileptic Disord"},{"key":"5772_CR216","doi-asserted-by":"publisher","first-page":"1215618","DOI":"10.3389\/fneur.2023.1215618","volume":"14","author":"V De Giorgis","year":"2023","unstructured":"De Giorgis V, Tagliabue A, Bisulli F, Brambilla I, Camerini A, Cusmai R, Darra F, Dianin A et al (2023) Ketogenic dietary therapies in epilepsy: recommendations of the Italian League against Epilepsy Dietary Therapy Study Group. Front Neurol 14:1215618","journal-title":"Front Neurol"},{"issue":"2","key":"5772_CR217","doi-asserted-by":"publisher","first-page":"177","DOI":"10.55782\/ane-2012-1890","volume":"72","author":"F Sefil","year":"2012","unstructured":"Sefil F, Bagirici F, Acar MD, Marangoz C (2012) Influence of carbenoxolone on the anticonvulsant efficacy of phenytoin in pentylenetetrazole kindled rats. Acta Neurobiol Exp (Wars) 72(2):177\u2013184. https:\/\/doi.org\/10.55782\/ane-2012-1890","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"1","key":"5772_CR218","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/01616412.2017.1384092","volume":"40","author":"J Franco-P\u00e9rez","year":"2018","unstructured":"Franco-P\u00e9rez J, Manjarrez-Marmolejo J, Rodr\u00edguez-Balderas C, Castro N, Ballesteros-Zebadua P (2018) Quinine and carbenoxolone enhance the anticonvulsant activity of some classical antiepileptic drugs. Neurol Res 40(1):26\u201333. https:\/\/doi.org\/10.1080\/01616412.2017.1384092","journal-title":"Neurol Res"},{"key":"5772_CR219","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neulet.2015.06.037","volume":"602","author":"J Franco-P\u00e9rez","year":"2015","unstructured":"Franco-P\u00e9rez J, Ballesteros-Zebad\u00faa P, Manjarrez-Marmolejo J (2015) Unilateral microinjection of carbenoxolone into the pontis caudalis nucleus inhibits the pentylenetetrazole-induced epileptiform activity in rats. Neurosci Lett 602:38\u201343. https:\/\/doi.org\/10.1016\/j.neulet.2015.06.037","journal-title":"Neurosci Lett"},{"issue":"3","key":"5772_CR220","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jphp.13040","volume":"71","author":"YJ Li","year":"2019","unstructured":"Li YJ, Wang L, Zhang B, Gao F, Yang CM (2019) Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus. J Pharm Pharmacol 71(3):390\u2013399. https:\/\/doi.org\/10.1111\/jphp.13040","journal-title":"J Pharm Pharmacol"},{"key":"5772_CR221","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainresbull.2020.08.008","volume":"164","author":"G Wu","year":"2020","unstructured":"Wu G, Liu J, Li S, Gao W, Qiu M, Yang C, Ma Y, Song X (2020) Glycyrrhizic acid protects juvenile epileptic rats against hippocampal damage through activation of Sirtuin3. Brain Res Bull 164:98\u2013106. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.08.008","journal-title":"Brain Res Bull"},{"issue":"2","key":"5772_CR222","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/kjm2.12642","volume":"39","author":"TT Yi","year":"2023","unstructured":"Yi TT, Zhang LM, Huang XN (2023) Glycyrrhizic acid protects against temporal lobe epilepsy in young rats by regulating neuronal ferroptosis through the miR-194-5p\/PTGS2 axis. Kaohsiung J Med Sci 39(2):154\u2013165. https:\/\/doi.org\/10.1002\/kjm2.12642","journal-title":"Kaohsiung J Med Sci"},{"issue":"18","key":"5772_CR223","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1021\/acschemneuro.0c00825","volume":"12","author":"YN Paudel","year":"2021","unstructured":"Paudel YN, Khan SU, Othman I, Shaikh MF (2021) Naturally occurring HMGB1 inhibitor, glycyrrhizin, modulates chronic seizures-induced memory dysfunction in zebrafish model. ACS Chem Neurosci 12(18):3288\u20133302. https:\/\/doi.org\/10.1021\/acschemneuro.0c00825","journal-title":"ACS Chem Neurosci"},{"key":"5772_CR224","doi-asserted-by":"publisher","unstructured":"Luo Z, Xu M, Zhang L, Zhang H, Xu Z, Xu Z (2023) Glycyrrhizin regulates the HMGB1\/P38MAPK signalling pathway in status epilepticus. Mol Med Rep 27(2). https:\/\/doi.org\/10.3892\/mmr.2023.12932","DOI":"10.3892\/mmr.2023.12932"},{"key":"5772_CR225","doi-asserted-by":"publisher","unstructured":"Lee DS, Kim TH, Park H, Kim JE (2022) CDDO-Me attenuates clasmatodendrosis in CA1 astrocyte by inhibiting HSP25-AKT mediated DRP1-S637 phosphorylation in chronic epilepsy rats. Int J Mol Sci 23(9). https:\/\/doi.org\/10.3390\/ijms23094569","DOI":"10.3390\/ijms23094569"},{"key":"5772_CR226","doi-asserted-by":"publisher","unstructured":"Kim JE, Park H, Lee JE, Kang TC (2020) CDDO-Me inhibits microglial activation and monocyte infiltration by abrogating NF\u03baB- and p38 MAPK-mediated signaling pathways following status epilepticus. Cells 9(5). https:\/\/doi.org\/10.3390\/cells9051123","DOI":"10.3390\/cells9051123"},{"key":"5772_CR227","doi-asserted-by":"publisher","unstructured":"Kim JE, Park H, Choi SH, Kong MJ, Kang TC (2019) CDDO-Me selectively attenuates CA1 neuronal death induced by status epilepticus via facilitating mitochondrial fission independent of LONP1. Cells 8(8). https:\/\/doi.org\/10.3390\/cells8080833","DOI":"10.3390\/cells8080833"},{"key":"5772_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2020.02.009","volume":"158","author":"XQ Su","year":"2020","unstructured":"Su XQ, Wang XY, Gong FT, Feng M, Bai JJ, Zhang RR, Dang XQ (2020) Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury. Brain Res Bull 158:1\u20138. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.02.009","journal-title":"Brain Res Bull"},{"issue":"19","key":"5772_CR229","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.008596","volume":"7","author":"R Wang","year":"2018","unstructured":"Wang R, Wu W, Li W, Huang S, Li Z, Liu R, Shan Z, Zhang C et al (2018) Activation of NLRP3 inflammasome promotes foam cell formation in vascular smooth muscle cells and atherogenesis via HMGB1. J Am Heart Assoc 7(19):e008596. https:\/\/doi.org\/10.1161\/jaha.118.008596","journal-title":"J Am Heart Assoc"},{"key":"5772_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118571","volume":"334","author":"YK Lin","year":"2024","unstructured":"Lin YK, Hong YL, Liu CY, Lin WQ, Liang K, Deng SQ, Zhang XJ, Zeng JX, Wang S (2024) Jiawei bai-hu-decoction ameliorated heat stroke-induced brain injury by inhibiting TLR4\/NF-\u03baB signal and mitophagy of glial cell. J Ethnopharmacol 334:118571. https:\/\/doi.org\/10.1016\/j.jep.2024.118571","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5772_CR231","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12974-020-01973-4","volume":"17","author":"H Fan","year":"2020","unstructured":"Fan H, Tang HB, Chen Z, Wang HQ, Zhang L, Jiang Y, Li T, Yang CF et al (2020) Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages\/microglia polarization and affords neuroprotection after spinal cord injury. J Neuroinflammation 17(1):295. https:\/\/doi.org\/10.1186\/s12974-020-01973-4","journal-title":"J Neuroinflammation"},{"key":"5772_CR232","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10936-w","author":"G Fu","year":"2024","unstructured":"Fu G, Kang X, Lin S (2024) Glycyrrhizic acid inhibits hippocampal neuron apoptosis by activating the PI3K\/ AKT signaling pathway. Biochem Genet. https:\/\/doi.org\/10.1007\/s10528-024-10936-w","journal-title":"Biochem Genet"},{"key":"5772_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118013","volume":"328","author":"S Ma","year":"2024","unstructured":"Ma S, Chong Y, Zhang R, Quan W, Gui J, Li L, Wang J, Miao S et al (2024) Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1\/2-dependent pathways. J Ethnopharmacol 328:118013. https:\/\/doi.org\/10.1016\/j.jep.2024.118013","journal-title":"J Ethnopharmacol"},{"key":"5772_CR234","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuroscience.2024.06.026","volume":"554","author":"JF Liang","year":"2024","unstructured":"Liang JF, Qin XD, Huang XH, Fan ZP, Zhi YY, Xu JW, Chen F, Pan ZL et al (2024) Glycyrrhetinic acid triggers a protective autophagy by inhibiting the JAK2\/STAT3 pathway in cerebral ischemia\/reperfusion injury. Neuroscience 554:96\u2013106. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.06.026","journal-title":"Neuroscience"},{"issue":"3","key":"5772_CR235","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14642","volume":"30","author":"Y Wang","year":"2024","unstructured":"Wang Y, Xiong Z, Qiao Y, Zhang Q, Zhou G, Zhou C, Ma X, Jiang X et al (2024) Acetyl-11-keto-beta-boswellic acid modulates macrophage polarization and Schwann cell migration to accelerate spinal cord injury repair in rats. CNS Neurosci Ther 30(3):e14642","journal-title":"CNS Neurosci Ther"},{"key":"5772_CR236","doi-asserted-by":"publisher","first-page":"116906","DOI":"10.1016\/j.taap.2024.116906","volume":"485","author":"D Pan","year":"2024","unstructured":"Pan D, Wang Q, Tang S, Wu X, Cai L, Wang Z, Li Y, Huang M et al (2024) Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy. Toxicol Appl Pharmacol 485:116906","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"5772_CR237","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s10753-023-01853-y","volume":"46","author":"RA Kachouei","year":"2023","unstructured":"Kachouei RA, Doagoo A, Jalilzadeh M, Khatami SH, Rajaei S, Jahan-Abad AJ, Salmani F, Pakrad R et al (2023) Acetyl-11-keto-beta-boswellic acid has therapeutic benefits for NAFLD rat models that were given a high fructose diet by ameliorating hepatic inflammation and lipid metabolism. Inflammation 46(5):1966\u20131980","journal-title":"Inflammation"},{"issue":"Suppl 1","key":"5772_CR238","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.4103\/sjkdt.sjkdt_41_22","volume":"34","author":"MR Sharifi","year":"2023","unstructured":"Sharifi MR, Hakimi Z, Ghalibaf MHE, Fazeli E, Behshti F, Marefati N, Hosseini M (2023) Acetyl-11-Keto-\u03b2-Boswellic acid and incensole acetate attenuate lipopolysaccharide-induced acute kidney injury by inhibiting inflammation and oxidative stress. Saudi J Kidney Dis Transpl 34(Suppl 1):S142\u2013S152","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"11","key":"5772_CR239","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3724\/abbs.2024102","volume":"56","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li X, Han Z, Qian Y, Bai L, Han Q, Gao M, Xue Y et al (2024) Acetyl-11-keto-\u03b2-boswellic acid restrains the progression of synovitis in osteoarthritis via the Nrf2\/HO-1 pathway: AKBA restrains OA via Nrf2\/HO-1. Acta Biochim Biophys Sin 56(11):1644","journal-title":"Acta Biochim Biophys Sin"},{"issue":"8","key":"5772_CR240","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes 13(8):1324","journal-title":"Genes"},{"issue":"12","key":"5772_CR241","doi-asserted-by":"publisher","first-page":"e08523","DOI":"10.1016\/j.heliyon.2021.e08523","volume":"7","author":"V Gunasekaran","year":"2021","unstructured":"Gunasekaran V, Avarachan J, Augustine A, Khayum ARA (2021) 3-O-Acetyl-11-keto-\u03b2-boswellic acid ameliorates acquired, consolidated and recognitive memory deficits through the regulation of hippocampal PPAR \u03b3, MMP9 and MMP2 genes in dementia model. Heliyon 7(12):e08523. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e08523","journal-title":"Heliyon"},{"key":"5772_CR242","doi-asserted-by":"publisher","DOI":"10.3390\/genes13081324","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes (Basel). https:\/\/doi.org\/10.3390\/genes13081324","journal-title":"Genes (Basel)"},{"key":"5772_CR243","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2020.02.022","volume":"150","author":"C Wei","year":"2020","unstructured":"Wei C, Fan J, Sun X, Yao J, Guo Y, Zhou B, Shang Y (2020) Acetyl-11-keto-\u03b2-boswellic acid ameliorates cognitive deficits and reduces amyloid-\u03b2 levels in APPswe\/PS1dE9 mice through antioxidant and anti-inflammatory pathways. Free Radic Biol Med 150:96\u2013108. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.022","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5772_CR244","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00109-024-02465-1","volume":"102","author":"T Hu","year":"2024","unstructured":"Hu T, Wei JW, Zheng JY, Luo QY, Hu XR, Du Q, Cai YF, Zhang SJ (2024) Metformin improves cognitive dysfunction through SIRT1\/NLRP3 pathway-mediated neuroinflammation in db\/db mice. J Mol Med (Berl) 102(9):1101\u20131115. https:\/\/doi.org\/10.1007\/s00109-024-02465-1","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"5772_CR245","doi-asserted-by":"publisher","first-page":"e14891","DOI":"10.1111\/cns.14891","volume":"30","author":"XQ Liu","year":"2024","unstructured":"Liu XQ, Huang S, Zheng JY, Wan C, Hu T, Cai YF, Wang Q, Zhang SJ (2024) Melatonin attenuates scopolamine-induced cognitive dysfunction through SIRT1\/IRE1\u03b1\/XBP1 pathway. CNS Neurosci Ther 30(7):e14891. https:\/\/doi.org\/10.1111\/cns.14891","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"5772_CR246","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1111\/cns.70068","volume":"30","author":"F Hao","year":"2024","unstructured":"Hao F, Zeng M, Cao B, Liang X, Ye K, Jiao X, Feng W, Zheng X (2024) Neobavaisoflavone ameliorates memory deficits and brain damage in A\u03b2(25\u201335)-induced mice by regulating SIRT1. CNS Neurosci Ther 30(10):e70068. https:\/\/doi.org\/10.1111\/cns.70068","journal-title":"CNS Neurosci Ther"},{"key":"5772_CR247","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuro.2023.08.001","volume":"98","author":"P Sethi","year":"2023","unstructured":"Sethi P, Mehan S, Khan Z, Chhabra S (2023) Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology 98:61\u201385. https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001","journal-title":"Neurotoxicology"},{"issue":"1","key":"5772_CR248","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13023-023-02665-x","volume":"18","author":"A Kubiliute","year":"2023","unstructured":"Kubiliute A, Gedvilaite G, Vilkeviciute A, Kriauciuniene L, Bruzaite A, Zaliuniene D, Liutkeviciene R (2023) The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis. Orphanet J Rare Dis 18(1):64. https:\/\/doi.org\/10.1186\/s13023-023-02665-x","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"5772_CR249","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/nu14030623","volume":"14","author":"JM Castellano","year":"2022","unstructured":"Castellano JM, Ramos-Romero S, Perona JS (2022) Oleanolic acid: extraction, characterization and biological activity. Nutrients 14(3):623","journal-title":"Nutrients"},{"key":"5772_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081161","author":"HN Nguyen","year":"2021","unstructured":"Nguyen HN, Ullevig SL, Short JD, Wang L, Ahn YJ, Asmis R (2021) Ursolic acid and related analogues: triterpenoids with broad health benefits. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10081161","journal-title":"Antioxidants"},{"key":"5772_CR251","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114559","volume":"210","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang Z, Fawcett JP, Gu J (2022) A novel, differential mobility spectrometry tandem mass spectrometric method for the in vivo quantitation of ursolic acid. J Pharm Biomed Anal 210:114559. https:\/\/doi.org\/10.1016\/j.jpba.2021.114559","journal-title":"J Pharm Biomed Anal"},{"issue":"9","key":"5772_CR252","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.3390\/ijms22094599","volume":"22","author":"E Gudoityte","year":"2021","unstructured":"Gudoityte E, Arandarcikaite O, Mazeikiene I, Bendokas V, Liobikas J (2021) Ursolic and oleanolic acids: plant metabolites with neuroprotective potential. Int J Mol Sci 22(9):4599","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5772_CR253","doi-asserted-by":"publisher","first-page":"1308749","DOI":"10.1155\/2020\/1308749","volume":"2020","author":"A Feng","year":"2020","unstructured":"Feng A, Yang S, Sun Y, Zhang L, Bo F, Li L (2020) Development and evaluation of oleanolic acid dosage forms and its derivatives. Biomed Res Int 2020(1):1308749","journal-title":"Biomed Res Int"},{"issue":"6","key":"5772_CR254","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/pharmaceutics16060692","volume":"16","author":"M Wasim","year":"2024","unstructured":"Wasim M, Bergonzi MC (2024) Unlocking the potential of oleanolic acid: integrating pharmacological insights and advancements in delivery systems. Pharmaceutics 16(6):692","journal-title":"Pharmaceutics"},{"issue":"1","key":"5772_CR255","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s43440-024-00684-4","volume":"77","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang X, Ma X, Wang X (2025) Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions. Pharmacol Rep 77(1):72\u201386. https:\/\/doi.org\/10.1007\/s43440-024-00684-4","journal-title":"Pharmacol Rep"},{"key":"5772_CR256","doi-asserted-by":"publisher","first-page":"117277","DOI":"10.1016\/j.taap.2025.117277","volume":"497","author":"Y Xu","year":"2025","unstructured":"Xu Y, Yang X, Lu Y, Liu J (2025) Hepatotoxicity from long-term administration of hepatoprotective low doses of oleanolic acid in mice. Toxicol Appl Pharmacol 497:117277","journal-title":"Toxicol Appl Pharmacol"},{"key":"5772_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139761","volume":"297","author":"Z Gu","year":"2025","unstructured":"Gu Z, Deng M, Luo Q, Lin S, Yu J, Li C, Wang X, Chen L et al (2025) Harnessing HDAC-targeted oleanolic acid derivatives for combined anti-cancer and hepatoprotective effects. Int J Biol Macromol 297:139761","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"5772_CR258","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/10520295.2021.1954691","volume":"97","author":"H Iskender","year":"2022","unstructured":"Iskender H, Dokumacioglu E, Terim Kapakin KA, Yenice G, Mohtare B, Bolat I, Hayirli A (2022) Effects of oleanolic acid on inflammation and metabolism in diabetic rats. Biotech Histochem 97(4):269\u2013276","journal-title":"Biotech Histochem"},{"key":"5772_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.074","volume":"636","author":"Y Liu","year":"2022","unstructured":"Liu Y, Hu Z, Xing H, Kang L, Chen X, Liu B, Niu K (2022) Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease. Biochem Biophys Res Commun 636:1\u20139","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5772_CR260","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/10286020.2022.2120863","volume":"25","author":"C-X Gao","year":"2023","unstructured":"Gao C-X, Tang C-H, Wu T-J, Hu Y, Peng Y-L, Liu M-L, Liu Q-W, Chen H-F et al (2023) Anticancer activity of oleanolic acid and its derivatives modified at A-ring and C-28 position. J Asian Nat Prod Res 25(6):581\u2013594","journal-title":"J Asian Nat Prod Res"},{"key":"5772_CR261","doi-asserted-by":"publisher","first-page":"109619","DOI":"10.1016\/j.cbi.2021.109619","volume":"347","author":"J-S Woo","year":"2021","unstructured":"Woo J-S, Yoo E-S, Kim S-H, Lee J-H, Han S-H, Jung S-H, Jung G-H, Jung J-Y (2021) Anticancer effects of oleanolic acid on human melanoma cells. Chem Biol Interact 347:109619","journal-title":"Chem Biol Interact"},{"key":"5772_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116567","volume":"315","author":"F Zhao","year":"2023","unstructured":"Zhao F, Peng C, Li H, Chen H, Yang Y, Ai Q, Chen N, Liu F (2023) Paeoniae Radix Rubra extract attenuates cerebral ischemia injury by inhibiting ferroptosis and activating autophagy through the PI3K\/Akt signalling pathway. J Ethnopharmacol 315:116567. https:\/\/doi.org\/10.1016\/j.jep.2023.116567","journal-title":"J Ethnopharmacol"},{"key":"5772_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914771","author":"P Lei","year":"2023","unstructured":"Lei P, Li Z, Hua Q, Song P, Gao L, Zhou L, Cai Q (2023) Ursolic acid alleviates neuroinflammation after intracerebral hemorrhage by mediating microglial pyroptosis via the NF-\u03baB\/NLRP3\/GSDMD pathway. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241914771","journal-title":"Int J Mol Sci"},{"key":"5772_CR264","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.brainres.2012.12.032","volume":"1497","author":"L Li","year":"2013","unstructured":"Li L, Zhang X, Cui L, Wang L, Liu H, Ji H, Du Y (2013) Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice. Brain Res 1497:32\u201339. https:\/\/doi.org\/10.1016\/j.brainres.2012.12.032","journal-title":"Brain Res"},{"issue":"4","key":"5772_CR265","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1536\/ihj.21-807","volume":"63","author":"Z Bian","year":"2022","unstructured":"Bian Z, Xu F, Liu H, Du Y (2022) Ursolic acid ameliorates the injury of H9c2 cells caused by hypoxia and reoxygenation through mediating CXCL2\/NF-\u03baB pathway. Int Heart J 63(4):755\u2013762. https:\/\/doi.org\/10.1536\/ihj.21-807","journal-title":"Int Heart J"},{"key":"5772_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112463","volume":"138","author":"Y Shi","year":"2024","unstructured":"Shi Y, Liu J, Hou M, Tan Z, Chen F, Zhang J, Liu Y, Leng Y (2024) Ursolic acid improves necroptosis via STAT3 signaling in intestinal ischemia\/reperfusion injury. Int Immunopharmacol 138:112463. https:\/\/doi.org\/10.1016\/j.intimp.2024.112463","journal-title":"Int Immunopharmacol"},{"key":"5772_CR267","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110258","volume":"120","author":"H Zhang","year":"2023","unstructured":"Zhang H, Xing Z, Zheng J, Shi J, Cui C (2023) Ursolic acid ameliorates traumatic brain injury in mice by regulating microRNA-141-mediated PDCD4\/PI3K\/AKT signaling pathway. Int Immunopharmacol 120:110258. https:\/\/doi.org\/10.1016\/j.intimp.2023.110258","journal-title":"Int Immunopharmacol"},{"key":"5772_CR268","doi-asserted-by":"publisher","unstructured":"Lin K, Zhang Z, Zhang Z, Zhu P, Jiang X, Wang Y, Deng Q, Lam Yung KK et al (2021) Oleanolic acid alleviates cerebral ischemia\/reperfusion injury via regulation of the GSK-3\u03b2\/HO-1 signaling pathway. Pharmaceuticals (Basel) 15(1). https:\/\/doi.org\/10.3390\/ph15010001","DOI":"10.3390\/ph15010001"},{"issue":"1","key":"5772_CR269","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4062\/biomolther.2021.154","volume":"30","author":"A Sapkota","year":"2022","unstructured":"Sapkota A, Choi JW (2022) Oleanolic acid provides neuroprotection against ischemic stroke through the inhibition of microglial activation and NLRP3 inflammasome activation. Biomol Ther (Seoul) 30(1):55\u201363. https:\/\/doi.org\/10.4062\/biomolther.2021.154","journal-title":"Biomol Ther (Seoul)"},{"issue":"5","key":"5772_CR270","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/1028415x.2022.2051957","volume":"26","author":"C Chen","year":"2023","unstructured":"Chen C, Ai Q, Shi A, Wang N, Wang L, Wei Y (2023) Oleanolic acid and ursolic acid: therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders. Nutr Neurosci 26(5):414\u2013428. https:\/\/doi.org\/10.1080\/1028415x.2022.2051957","journal-title":"Nutr Neurosci"},{"issue":"4","key":"5772_CR271","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/molecules29040815","volume":"29","author":"R Turnaturi","year":"2024","unstructured":"Turnaturi R, Piana S, Spoto S, Costanzo G, Reina L, Pasquinucci L, Parenti C (2024) From plant to chemistry: sources of antinociceptive non-opioid active principles for medicinal chemistry and drug design. Molecules 29(4):815","journal-title":"Molecules"},{"issue":"4","key":"5772_CR272","first-page":"1252","volume":"15","author":"H Hosseinzadeh","year":"2025","unstructured":"Hosseinzadeh H, Ramazani E, Bakhshi S, Tayarani-Najaran Z (2025) Licorice extract and carbenoxolone protect PC12 cells against serum\/glucose deprivation-induced apoptosis through modulation of caspase-3 and PARP activation. Avicenna J Phytomed 15(4):1252","journal-title":"Avicenna J Phytomed"},{"key":"5772_CR273","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijbiomac.2020.07.086","volume":"164","author":"S Bharathala","year":"2020","unstructured":"Bharathala S, Singh R, Sharma P (2020) Controlled release and enhanced biological activity of chitosan-fabricated carbenoxolone nanoparticles. Int J Biol Macromol 164:45\u201352","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5772_CR274","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-018-1127-3","volume":"15","author":"X Yin","year":"2018","unstructured":"Yin X, Feng L, Ma D, Yin P, Wang X, Hou S, Hao Y, Zhang J et al (2018) Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation\/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone. J Neuroinflammation 15(1):97. https:\/\/doi.org\/10.1186\/s12974-018-1127-3","journal-title":"J Neuroinflammation"},{"issue":"11","key":"5772_CR275","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11094-024-03071-8","volume":"57","author":"E Karimova","year":"2024","unstructured":"Karimova E, Makara N, Sapozhnikova T, Baltina L (2024) Synthesis and antiulcer activity of aromatic and heterocyclic amides of 3-O-acetylglycyrrhetic acid. Pharm Chem J 57(11):1717\u20131725","journal-title":"Pharm Chem J"},{"key":"5772_CR276","doi-asserted-by":"publisher","unstructured":"de Swiet M (2023) Glycyrrhiza glabra: the source of carbenoxolone. Modern medicines from plants. Botanical Histories of Some of Modern Medicine\u2019s Most Important Drugs. CRC Press, pp 175\u2013179. https:\/\/doi.org\/10.1201\/9781003413004","DOI":"10.1201\/9781003413004"},{"issue":"1","key":"5772_CR277","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00210-020-01891-5","volume":"394","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Y, Zhu G, Sun C, Wang J (2021) Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride\u2013induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 394(1):189\u2013204. https:\/\/doi.org\/10.1007\/s00210-020-01891-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5772_CR278","doi-asserted-by":"crossref","unstructured":"Bhattarai AK, Dixit SM (2020) Ethnomedicinal and pharmacological importance of Glycyrrhiza glabra L. Wild plants. CRC Press, pp 444\u2013456","DOI":"10.1201\/9781003020134-21"},{"key":"5772_CR279","doi-asserted-by":"publisher","unstructured":"Kundu S, Singh S (2023) Protective mechanisms of 3-acetyl-11-keto-\u03b2-boswellic acid and piperine in fluid percussion rat model of traumatic brain injury targeting Nrf2 and NFkB signaling. Neurotox Res: 41(1):57\u201384. https:\/\/doi.org\/10.1007\/s12640-022-00628-x","DOI":"10.1007\/s12640-022-00628-x"},{"issue":"10","key":"5772_CR280","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.7754\/clin.lab.2015.150215","volume":"61","author":"YK Wang","year":"2015","unstructured":"Wang YK, Deng F, Miao J, Xie H, Feng JC (2015) Neuroprotection by carbenoxolone against ischemia injury involves PI3K\/Akt pathway. Clin Lab 61(10):1561\u20131568. https:\/\/doi.org\/10.7754\/clin.lab.2015.150215","journal-title":"Clin Lab"},{"key":"5772_CR281","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112394","volume":"137","author":"M Sun","year":"2024","unstructured":"Sun M, Wang Q, Huang J, Sun Q, Yu Q, Liu X, Liu Z (2024) Asiatic acid induces ferroptosis of RA-FLS via the Nrf2\/HMOX1 pathway to relieve inflammation in rheumatoid arthritis. Int Immunopharmacol 137:112394. https:\/\/doi.org\/10.1016\/j.intimp.2024.112394","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"5772_CR282","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1002\/tox.24246","volume":"39","author":"YY Law","year":"2024","unstructured":"Law YY, Lee HL, Lin CL, Chen PN, Wang PH, Hsieh YH, Chen CM (2024) Asiatic acid inhibits osteosarcoma cell migration and invasion via the AKT\/Sp1\/MMP1 axis. Environ Toxicol 39(7):3920\u20133929. https:\/\/doi.org\/10.1002\/tox.24246","journal-title":"Environ Toxicol"},{"issue":"7","key":"5772_CR283","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1021\/acsami.3c14690","volume":"16","author":"W Zhang","year":"2024","unstructured":"Zhang W, Zhao S, Guan Q, Li P, Fan Y (2024) Enhancing chronic wound healing through engineering Mg(2+)-coordinated asiatic acid\/bacterial cellulose hybrid hydrogels. ACS Appl Mater Interfaces 16(7):8238\u20138249. https:\/\/doi.org\/10.1021\/acsami.3c14690","journal-title":"ACS Appl Mater Interfaces"},{"key":"5772_CR284","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117888","volume":"325","author":"Z Firdaus","year":"2024","unstructured":"Firdaus Z, Gutti G, Ganeshpurkar A, Kumar A, Krishnamurthy S, Singh SK, Singh TD (2024) Centella asiatica improves memory and executive function in middle-aged rats by controlling oxidative stress and cholinergic transmission. J Ethnopharmacol 325:117888. https:\/\/doi.org\/10.1016\/j.jep.2024.117888","journal-title":"J Ethnopharmacol"},{"key":"5772_CR285","doi-asserted-by":"publisher","first-page":"tkaf009","DOI":"10.1093\/burnst\/tkaf009","volume":"13","author":"X Mu","year":"2025","unstructured":"Mu X, Chen J, Zhu H, Deng J, Wu X, He W, Ye P, Gu R et al (2025) Asiaticoside\u2013nitric oxide synergistically accelerate diabetic wound healing by regulating key metabolites and SRC\/STAT3 signaling. Burns Trauma 13:tkaf009","journal-title":"Burns Trauma"},{"issue":"10","key":"5772_CR286","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.5455\/OVJ.2023.v13.i10.12","volume":"13","author":"A Ariani","year":"2023","unstructured":"Ariani A, Khotimah H, Nurdiana N, Rahayu M (2023) Asiatic acid increased locomotor and head width by inducing brain-derived neurotrophic factor in intrauterine hypoxia-exposed zebrafish. Open Vet J 13(10):1326\u20131333. https:\/\/doi.org\/10.5455\/OVJ.2023.v13.i10.12","journal-title":"Open Vet J"},{"key":"5772_CR287","doi-asserted-by":"publisher","first-page":"106175","DOI":"10.1016\/j.archoralbio.2025.106175","volume":"172","author":"P Sumrejkanchanakij","year":"2025","unstructured":"Sumrejkanchanakij P, Fitri AR, Pavasant P, Chareonvit S, Lin ACK, Chamni S (2025) Asiatic acid methyl ester, a new asiaticoside derivative, induces osteogenic differentiation of hPDLCs. Arch Oral Biol 172:106175","journal-title":"Arch Oral Biol"},{"key":"5772_CR288","doi-asserted-by":"publisher","DOI":"10.1177\/09731296241312483","author":"L Li","year":"2025","unstructured":"Li L, Liu L, Wang T (2025) Effects of asiaticosides on scar recovery and psychological well-being in patients with scald injuries. Pharmacogn Mag. https:\/\/doi.org\/10.1177\/09731296241312483","journal-title":"Pharmacogn Mag"},{"key":"5772_CR289","doi-asserted-by":"crossref","unstructured":"Soe ZC, Nan DN, Wahyudi R, Vongsutilers V, Kamolratanakul P, Everts V, Osathanon T, Limjeerajarus CN, Limjeerajarus N (2025) Asiaticoside-loaded nanosponges hydrogel has an anti-inflammatory effect and promotes human dental pulp regeneration. J Endod 51(7):931-8","DOI":"10.1016\/j.joen.2025.04.004"},{"key":"5772_CR290","doi-asserted-by":"publisher","unstructured":"Zhou A, Feng H-Y, Fan C-N, Wang J, Yuan Z-Y, Xu G-H, Li C-F, Huang W-F et al (2025) Asiaticoside attenuates chronic restraint stress-induced hippocampal CA1 neuronal ferroptosis via activating BDNF\/Nrf2\/GPX4 signaling pathway. Drug Des Devel Ther 793-810. https:\/\/doi.org\/10.2147\/DDDT.S509208","DOI":"10.2147\/DDDT.S509208"},{"key":"5772_CR291","doi-asserted-by":"publisher","unstructured":"Poleszak E, Wo\u015bko S, Szewczyk B, Wyska E, Szopa A, Wr\u00f3bel A, Szponar J, Wla\u017a P et al (2025) Asiatic acid potentiates the activity of common antidepressant drugs in mice. Psychopharmacology :1-13. https:\/\/doi.org\/10.1007\/s00213-025-06827-6","DOI":"10.1007\/s00213-025-06827-6"},{"issue":"5","key":"5772_CR292","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70555","volume":"15","author":"X Li","year":"2025","unstructured":"Li X, Tong J, Yuan X, Zhang X, Yu H, Xing C, Wu J, Qiu Y et al (2025) Infralimbic GABAergic may be the target of asiaticoside on alleviating bone cancer pain. Brain Behav 15(5):e70555","journal-title":"Brain Behav"},{"key":"5772_CR293","doi-asserted-by":"crossref","unstructured":"Frolova LN, Kovaleva EL, Shelestova VV, Kuteynikov VY, Flisyuk EV, Pozharitskaya ON, Shikov AN (2025) Comparison of analytical methods used for standardization of triterpenoid saponins in herbal monographs included in the Russian and other pharmacopeias. Phytochemical Analysis","DOI":"10.1002\/pca.3516"},{"issue":"2","key":"5772_CR294","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s11101-024-09956-6","volume":"24","author":"S Fazliev","year":"2025","unstructured":"Fazliev S, Tursunov K, Sharipov A, Xaydarov V, Normakhamatov N, Rizaev K, Wang T, Aisa HA (2025) Escin\u2019s phytochemistry and pharmacy: biosynthesis, chemistry, synergism and novel activities. Phytochem Rev 24(2):1345\u20131363. https:\/\/doi.org\/10.1007\/s11101-024-09956-6","journal-title":"Phytochem Rev"},{"key":"5772_CR295","doi-asserted-by":"publisher","DOI":"10.17816\/2311-2905-17695","author":"VA Prikhodko","year":"2025","unstructured":"Prikhodko VA, Okovityi SV (2025) Systemic administration of escin for posttraumatic or post-operative soft tissue edema: a systematic review of randomized clinical trials. Traumatol Ortop Rossii. https:\/\/doi.org\/10.17816\/2311-2905-17695","journal-title":"Traumatol Ortop Rossii"},{"key":"5772_CR296","doi-asserted-by":"publisher","unstructured":"Kakamad FH, Tahir SH, Mohammed Saeed DH, Ahmed FJ, Hiwa DS, Abdalla BA, Mustafa AM, Hassan MN et al (2025) Role of veno-active drugs after endovenous therapy: a systematic review of the current literature. Phlebology 02683555251337265. https:\/\/doi.org\/10.1177\/02683555251337265","DOI":"10.1177\/02683555251337265"},{"issue":"4","key":"5772_CR297","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/jmf.2024.0180","volume":"28","author":"M So\u0142tysiak","year":"2025","unstructured":"So\u0142tysiak M, Koziak K, Dutkiewicz M, Zegrocka-Stendel O, Misiukiewicz-St\u0119pie\u0144 P, Krenke R, Papli\u0144ska-Goryca M (2025) \u03b2-Escin and Chokeberry fruit extract supplementation in smokers as potential anti-inflammatory protection\u2014a pilot proof-of-concept study. J Med Food 28(4):402\u2013406","journal-title":"J Med Food"},{"key":"5772_CR298","doi-asserted-by":"publisher","unstructured":"Yanqin D et al (2025) \u03b2-escin mitigates neuroinflammation and apoptosis caused by ischemic stroke through the inhibition of the interleukin-6\/Janus kinase 2\/signal transducer and activator of transcription 3 signaling pathway. J Int Med Res 53(12):3000605251400652. https:\/\/doi.org\/10.1177\/03000605251400652","DOI":"10.1177\/03000605251400652"},{"key":"5772_CR299","doi-asserted-by":"publisher","first-page":"113554","DOI":"10.1016\/j.expneurol.2020.113554","volume":"337","author":"YX Ding","year":"2021","unstructured":"Ding YX, Eerduna GW, Duan SJ, Li T, Liu RX, Zhang LM, Wang T, Fu FH (2021) Escin ameliorates the impairments of neurological function and blood brain barrier by inhibiting systemic inflammation in intracerebral hemorrhagic mice. Exp Neurol 337:113554","journal-title":"Exp Neurol"},{"issue":"2","key":"5772_CR300","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/med.21751","volume":"41","author":"Y Lu","year":"2021","unstructured":"Lu Y, Liu Y, Zhou J, Li D, Gao W (2021) Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol. Med Res Rev 41(2):1022\u20131060","journal-title":"Med Res Rev"},{"key":"5772_CR301","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.988748","volume":"13","author":"JP Ng","year":"2022","unstructured":"Ng JP, Han Y, Yang LJ, Birkholtz L-M, Coertzen D, Wong HN, Haynes RK, Coghi P et al (2022) Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue. Front Pharmacol 13:988748","journal-title":"Front Pharmacol"},{"key":"5772_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114882","volume":"163","author":"C Wang","year":"2023","unstructured":"Wang C, Dai S, Zhao X, Zhang Y, Gong L, Fu K, Ma C, Peng C et al (2023) Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies. Biomed Pharmacother 163:114882","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"5772_CR303","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41557-023-01245-7","volume":"15","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Hansen NL, Duan Y-T, Prasad M, Motawia MS, M\u00f8ller BL, Pateraki I, Staerk D et al (2023) Biosynthesis and biotechnological production of the anti-obesity agent celastrol. Nat Chem 15(9):1236\u20131246","journal-title":"Nat Chem"},{"issue":"9","key":"5772_CR304","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1021\/acs.jnatprod.0c00067","volume":"83","author":"Q-W He","year":"2020","unstructured":"He Q-W, Feng J-H, Hu X-L, Long H, Huang X-F, Jiang Z-Z, Zhang X-Q, Ye W-C et al (2020) Synthesis and biological evaluation of celastrol derivatives as potential immunosuppressive agents. J Nat Prod 83(9):2578\u20132586","journal-title":"J Nat Prod"},{"key":"5772_CR305","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001057","author":"T Xie","year":"2024","unstructured":"Xie T, Rui H, Liu H, Liu X, Liu X, Li P (2024) Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL\/lpr mice. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2023-001057","journal-title":"Lupus Sci Med"},{"issue":"1","key":"5772_CR306","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/aijpms.2022.151773.1154","volume":"3","author":"SG Ibrahim","year":"2023","unstructured":"Ibrahim SG, Mohamed EA, Abd Ellah MF, Ali AA (2023) The reno-protective effect of celastrol mediated by Nrf2\/HO-1 activation and NF-\u03baB\/NLRP3 suppression in hepatic ischemia\/reperfusion model. Azhar International Journal of Pharmaceutical and Medical Sciences 3(1):1\u201314","journal-title":"Azhar International Journal of Pharmaceutical and Medical Sciences"},{"issue":"1","key":"5772_CR307","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12013-022-01064-6","volume":"80","author":"NS Younis","year":"2022","unstructured":"Younis NS, Ghanim AMH (2022) The protective role of celastrol in renal ischemia-reperfusion injury by activating Nrf2\/HO-1, PI3K\/AKT signaling pathways, modulating NF-\u03bab signaling pathways, and inhibiting ERK phosphorylation. Cell Biochem Biophys 80(1):191\u2013202","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"5772_CR308","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11064-025-04375-1","volume":"50","author":"F Cao","year":"2025","unstructured":"Cao F, Zhang P, Chi Y, Wang Y, Xu L, Zhang D (2025) Celastrol ameliorated Alzheimer\u2019s disease in mice by enhancing TBX21\/TREM2 expression in microglia and inhibiting tau phosphorylation. Neurochem Res 50(2):126","journal-title":"Neurochem Res"},{"issue":"3","key":"5772_CR309","doi-asserted-by":"publisher","first-page":"815","DOI":"10.14336\/AD.2021.1115","volume":"13","author":"D Liu","year":"2022","unstructured":"Liu D, Zhang Q, Luo P, Gu L, Shen S, Tang H, Zhang Y, Lyu M et al (2022) Neuroprotective effects of celastrol in neurodegenerative diseases-unscramble its major mechanisms of action and targets. Aging Dis 13(3):815","journal-title":"Aging Dis"},{"key":"5772_CR310","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26154700","author":"S Schiavone","year":"2021","unstructured":"Schiavone S, Morgese MG, Tucci P, Trabace L (2021) The therapeutic potential of celastrol in central nervous system disorders: highlights from in vitro and in vivo approaches. Molecules. https:\/\/doi.org\/10.3390\/molecules26154700","journal-title":"Molecules"},{"issue":"6","key":"5772_CR311","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30061275","volume":"30","author":"W Wang","year":"2025","unstructured":"Wang W, Jin Y, Liu M-K, Zhang S-Y, Chen H, Song J (2025) Current progress of hederagenin and its derivatives for disease therapy (2017\u2013present). Molecules 30(6):1275","journal-title":"Molecules"},{"issue":"10","key":"5772_CR312","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1039\/D3MD00296A","volume":"14","author":"X Huang","year":"2023","unstructured":"Huang X, Shen Q-K, Guo H-Y, Li X, Quan Z-S (2023) Pharmacological overview of hederagenin and its derivatives. RSC Med Chem 14(10):1858\u20131884","journal-title":"RSC Med Chem"},{"key":"5772_CR313","doi-asserted-by":"publisher","first-page":"1374264","DOI":"10.3389\/fphar.2024.1374264","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li Y, Liu Y (2024) An updated review of the pharmacological effects and potential mechanisms of hederagenin and its derivatives. Front Pharmacol 15:1374264","journal-title":"Front Pharmacol"},{"key":"5772_CR314","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fphar.2020.01173","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, Song L, Cao X, Li W, Zhao Y, Chen J, Li J, Chen Y et al (2020) Hederagenin attenuates cerebral ischaemia\/reperfusion injury by regulating MLK3 signalling. Front Pharmacol 11:1173. https:\/\/doi.org\/10.3389\/fphar.2020.01173","journal-title":"Front Pharmacol"},{"issue":"3","key":"5772_CR315","volume":"74","author":"Dutra M da Silva","year":"2025","unstructured":"da Silva Dutra M, Ara\u00fajo PRM, da Gleiciane Rocha M, Pereira VC, Freitas AS, Pereira Lopes RG, Souza PFN, Montenegro RC et al (2025) Antimicrobial and antiparasitic potential of lupeol: antifungal effect on the Candida parapsilosis species complex and nematicidal activity against Caenorhabditis elegans. J Med Microbiol 74(3):001976","journal-title":"J Med Microbiol"},{"key":"5772_CR316","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155777","volume":"132","author":"H Fatma","year":"2024","unstructured":"Fatma H, Jameel M, Siddiqui AJ, Kuddus M, Buali NS, Bahrini I, Siddique HR (2024) Chemotherapeutic potential of lupeol against cancer in pre-clinical model: a systematic review and meta-analysis. Phytomedicine 132:155777","journal-title":"Phytomedicine"},{"key":"5772_CR317","doi-asserted-by":"publisher","first-page":"113068","DOI":"10.1016\/j.fct.2022.113068","volume":"164","author":"M Coremen","year":"2022","unstructured":"Coremen M, Turkyilmaz IB, Us H, Us AS, Celik S, Ozel AE, Bulan OK, Yanardag R (2022) Lupeol inhibits pesticides induced hepatotoxicity via reducing oxidative stress and inflammatory markers in rats. Food Chem Toxicol 164:113068","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"5772_CR318","first-page":"1","volume":"7","author":"NM Musa","year":"2024","unstructured":"Musa NM, Sallau MS, Oyewale AO, Ali T (2024) Antimicrobial activity of lupeol and \u03b2-amyrin (triterpenoids) isolated from the rhizome of Dolichos pachyrhizus harm. Advanced Journal of Chemistry, Section A 7(1):1\u201314","journal-title":"Advanced Journal of Chemistry, Section A"},{"issue":"8","key":"5772_CR319","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/s41401-021-00820-3","volume":"43","author":"D Li","year":"2022","unstructured":"Li D, Guo Y-y, Cen X-f, Qiu H-l, Chen S, Zeng X-f, Zeng Q, Xu M, Tang Q-z (2022) Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-\u03baB pathways. Acta Pharmacol Sin 43(8):1989\u20132002","journal-title":"Acta Pharmacol Sin"},{"key":"5772_CR320","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s237406","author":"Z Wang","year":"2020","unstructured":"Wang Z, Han Y, Tian S, Bao J, Wang Y, Jiao J (2020) Lupeol alleviates cerebral ischemia\u2013reperfusion injury in correlation with modulation of PI3K\/Akt pathway. Neuropsychiatr Dis Treat. https:\/\/doi.org\/10.2147\/ndt.s237406","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"13","key":"5772_CR321","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/nu15133059","volume":"15","author":"JS Park","year":"2023","unstructured":"Park JS, Rehman IU, Choe K, Ahmad R, Lee HJ, Kim MO (2023) A triterpenoid lupeol as an antioxidant and anti-neuroinflammatory agent: impacts on oxidative stress in Alzheimer\u2019s disease. Nutrients 15(13):3059","journal-title":"Nutrients"},{"key":"5772_CR322","doi-asserted-by":"publisher","first-page":"100548","DOI":"10.1016\/j.obmed.2024.100548","volume":"49","author":"LS Singh","year":"2024","unstructured":"Singh LS, Singh WS (2024) Multifaceted therapeutic potential of corosolic acid: a novel bioactive compound. Obes Med 49:100548","journal-title":"Obes Med"},{"issue":"2","key":"5772_CR323","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12345","volume":"21","author":"J Zhao","year":"2021","unstructured":"Zhao J, Zhou H, An Y, Shen K, Yu L (2021) Biological effects of corosolic acid as an anti-inflammatory, anti-metabolic syndrome and anti-neoplasic natural compound. Oncol Lett 21(2):84","journal-title":"Oncol Lett"},{"key":"5772_CR324","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105256","volume":"97","author":"M Hibi","year":"2022","unstructured":"Hibi M, Matsui Y, Niwa S, Oishi S, Yanagimoto A, Ono T, Yamaguchi T (2022) Corosolic acid improves glucose and insulin responses in middle-aged men with impaired fasting glucose: a randomized, double-blinded, placebo-controlled crossover trial. J Funct Foods 97:105256","journal-title":"J Funct Foods"},{"issue":"10","key":"5772_CR325","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.5650\/jos.ess22130","volume":"71","author":"L Zhang","year":"2022","unstructured":"Zhang L, Sui S, Wang S, Sun J (2022) Neuroprotective effect of corosolic acid against cerebral ischemia-reperfusion injury in experimental rats. J Oleo Sci 71(10):1501\u20131510","journal-title":"J Oleo Sci"},{"issue":"4","key":"5772_CR326","doi-asserted-by":"publisher","first-page":"126947","DOI":"10.1016\/j.bmcl.2019.126947","volume":"30","author":"S-H Xu","year":"2020","unstructured":"Xu S-H, Chen H-l, Fan Y, Xu W, Zhang J (2020) Application of tandem biotransformation for biosynthesis of new pentacyclic triterpenoid derivatives with neuroprotective effect. Bioorg Med Chem Lett 30(4):126947","journal-title":"Bioorg Med Chem Lett"},{"key":"5772_CR327","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118464","volume":"334","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ge F, Luo Y, Ji X, Liu Z, Qiu Y, Hou J, Zhou R et al (2024) Paeonol and glycyrrhizic acid in combination ameliorate the recurrent nitroglycerin-induced migraine-like phenotype in rats by regulating the GABBR2\/TRPM8\/PRKACA\/TRPV1 pathway. J Ethnopharmacol 334:118464. https:\/\/doi.org\/10.1016\/j.jep.2024.118464","journal-title":"J Ethnopharmacol"},{"key":"5772_CR328","doi-asserted-by":"publisher","unstructured":"Karima S, Khatami SH, Ehtiati S, Khoshtinatnikkhouy S, Kachouei RA, Jahan-Abad AJ, Tafakhori A, Firoozpour H et al (2024) Acetyl 11-keto beta-boswellic acid improves neurological functions in a mouse model of multiple sclerosis. Inflammation. https:\/\/doi.org\/10.1007\/s10753-024-02176-2","DOI":"10.1007\/s10753-024-02176-2"},{"key":"5772_CR329","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1038\/srep07002","volume":"4","author":"Y Ding","year":"2014","unstructured":"Ding Y, Chen M, Wang M, Wang M, Zhang T, Park J, Zhu Y, Guo C et al (2014) Neuroprotection by acetyl-11-keto-\u03b2-boswellic acid, in ischemic brain injury involves the Nrf2\/HO-1 defense pathway. Sci Rep 4:7002. https:\/\/doi.org\/10.1038\/srep07002","journal-title":"Sci Rep"},{"issue":"2","key":"5772_CR330","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/0113816128269289231226115446","volume":"30","author":"AH Assaran","year":"2024","unstructured":"Assaran AH, Hosseini M, Shirazinia M, Ghalibaf MHE, Beheshti F, Mobasheri L, Mirzavi F, Rajabian A (2024) Neuro-protective effect of acetyl-11-keto-\u03b2-boswellic acid in a rat model of scopolamine-induced cholinergic dysfunction. Curr Pharm Des 30(2):140\u2013150. https:\/\/doi.org\/10.2174\/0113816128269289231226115446","journal-title":"Curr Pharm Des"},{"issue":"1","key":"5772_CR331","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000097627","volume":"79","author":"M Bishnoi","year":"2007","unstructured":"Bishnoi M, Patil CS, Kumar A, Kulkarni SK (2007) Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice. Pharmacology 79(1):34\u201341. https:\/\/doi.org\/10.1159\/000097627","journal-title":"Pharmacology"},{"key":"5772_CR332","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1058358","volume":"13","author":"FJ Mirza","year":"2022","unstructured":"Mirza FJ, Zahid S (2022) Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer\u2019s disease. Front Pharmacol 13:1058358. https:\/\/doi.org\/10.3389\/fphar.2022.1058358","journal-title":"Front Pharmacol"},{"key":"5772_CR333","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.116883","volume":"484","author":"Y Yang","year":"2024","unstructured":"Yang Y, He Z, Wu S (2024) Ursolic acid alleviates paclitaxel-induced peripheral neuropathy through PPAR\u03b3 activation. Toxicol Appl Pharmacol 484:116883. https:\/\/doi.org\/10.1016\/j.taap.2024.116883","journal-title":"Toxicol Appl Pharmacol"},{"key":"5772_CR334","doi-asserted-by":"publisher","first-page":"1403974","DOI":"10.3389\/fncel.2024.1403974","volume":"18","author":"EA Ucar","year":"2024","unstructured":"Ucar EA, Ozkan E, Shomalizadeh N, Sekerda\u011f-Kilic E, Akpunar F, Sapanci S, Kesibi J, Ozler C et al (2024) Carbenoxolone mitigates extensive fibrosis formation in PLP-induced EAE model and multiple sclerosis serum-exposed pericyte culture. Front Cell Neurosci 18:1403974. https:\/\/doi.org\/10.3389\/fncel.2024.1403974","journal-title":"Front Cell Neurosci"},{"key":"5772_CR335","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2018.09.018","volume":"839","author":"YW Han","year":"2018","unstructured":"Han YW, Liu XJ, Zhao Y, Li XM (2018) Role of oleanolic acid in maintaining BBB integrity by targeting p38MAPK\/VEGF\/Src signaling pathway in rat model of subarachnoid hemorrhage. Eur J Pharmacol 839:12\u201320. https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.018","journal-title":"Eur J Pharmacol"},{"key":"5772_CR336","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173811","volume":"893","author":"Y Han","year":"2021","unstructured":"Han Y, Tong Z, Wang C, Li X, Liang G (2021) Oleanolic acid exerts neuroprotective effects in subarachnoid hemorrhage rats through SIRT1-mediated HMGB1 deacetylation. Eur J Pharmacol 893:173811. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173811","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5772_CR337","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-1009-0","volume":"14","author":"JH Park","year":"2017","unstructured":"Park JH, Seo YH, Jang JH, Jeong CH, Lee S, Park B (2017) Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB\/STAT3\/ERK and mitochondria-mediated apoptosis pathway. J Neuroinflammation 14(1):240. https:\/\/doi.org\/10.1186\/s12974-017-1009-0","journal-title":"J Neuroinflammation"},{"key":"5772_CR338","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110208","volume":"262","author":"Y Hu","year":"2025","unstructured":"Hu Y, Gu J, Jin X, Wu X, Li H, Bai L, Wu J, Li X Sr (2025) Asiatic acid alleviates subarachnoid hemorrhage-induced brain injury in rats by inhibiting ferroptosis of neurons via targeting acyl-coenzyme a oxidase 1. Neuropharmacology 262:110208. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110208","journal-title":"Neuropharmacology"},{"issue":"9","key":"5772_CR339","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23843","volume":"38","author":"J Wang","year":"2024","unstructured":"Wang J, Wang J (2024) Asiaticoside protected brain injury in hypertensive intracerebral hemorrhage via activation of the PI3K\/AKT pathway. J Biochem Mol Toxicol 38(9):e23843. https:\/\/doi.org\/10.1002\/jbt.23843","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"5772_CR340","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.3892\/mmr.2020.11305","volume":"22","author":"L Wang","year":"2020","unstructured":"Wang L, Guo T, Guo Y, Xu Y (2020) Asiaticoside produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice, involving reversion of inflammation and the PKA\/pCREB\/BDNF signaling pathway. Mol Med Rep 22(3):2364\u20132372. https:\/\/doi.org\/10.3892\/mmr.2020.11305","journal-title":"Mol Med Rep"},{"key":"5772_CR341","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155494","volume":"127","author":"Z He","year":"2024","unstructured":"He Z, Hu Y, Zhang Y, Xie J, Niu Z, Yang G, Zhang J, Zhao Z et al (2024) Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation. Phytomedicine 127:155494. https:\/\/doi.org\/10.1016\/j.phymed.2024.155494","journal-title":"Phytomedicine"},{"key":"5772_CR342","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112592","volume":"138","author":"M Li","year":"2024","unstructured":"Li M, Fu F, Wang T (2024) Escin alleviates cerebral ischemia-induced intestinal pyroptosis via the GR-dependent p38 MAPK\/NF-\u03baB signaling and NLRP3 inflammasome activation. Int Immunopharmacol 138:112592. https:\/\/doi.org\/10.1016\/j.intimp.2024.112592","journal-title":"Int Immunopharmacol"},{"key":"5772_CR343","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00847","volume":"14","author":"B Zhang","year":"2020","unstructured":"Zhang B, Zhong Q, Chen X, Wu X, Sha R, Song G, Zhang C, Chen X (2020) Neuroprotective effects of celastrol on transient global cerebral ischemia rats via regulating HMGB1\/NF-\u03baB signaling pathway. Front Neurosci 14:847. https:\/\/doi.org\/10.3389\/fnins.2020.00847","journal-title":"Front Neurosci"},{"issue":"1","key":"5772_CR344","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-021-02216-w","volume":"18","author":"DD Liu","year":"2021","unstructured":"Liu DD, Luo P, Gu L, Zhang Q, Gao P, Zhu Y, Chen X, Guo Q et al (2021) Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion. J Neuroinflammation 18(1):174. https:\/\/doi.org\/10.1186\/s12974-021-02216-w","journal-title":"J Neuroinflammation"},{"key":"5772_CR345","doi-asserted-by":"publisher","first-page":"7420507","DOI":"10.1155\/2022\/7420507","volume":"2022","author":"M Chen","year":"2022","unstructured":"Chen M, Liu M, Luo Y, Cao J, Zeng F, Yang L, Yang J, Tao T et al (2022) Celastrol protects against cerebral ischemia\/reperfusion injury in mice by inhibiting glycolysis through targeting HIF-1\u03b1\/PDK1 axis. Oxid Med Cell Longev 2022:7420507. https:\/\/doi.org\/10.1155\/2022\/7420507","journal-title":"Oxid Med Cell Longev"},{"key":"5772_CR346","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154711","volume":"112","author":"ZS Xie","year":"2023","unstructured":"Xie ZS, Zhao JP, Wu LM, Chu S, Cui ZH, Sun YR, Wang H, Ma HF et al (2023) Hederagenin improves Alzheimer\u2019s disease through PPAR\u03b1\/TFEB-mediated autophagy. Phytomedicine 112:154711. https:\/\/doi.org\/10.1016\/j.phymed.2023.154711","journal-title":"Phytomedicine"},{"key":"5772_CR347","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116086","author":"R Ahmad","year":"2022","unstructured":"Ahmad R, Khan A, Rehman IU, Lee HJ, Khan I, Kim MO (2022) Lupeol treatment attenuates activation of glial cells and oxidative-stress-mediated neuropathology in mouse model of traumatic brain injury. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116086","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5772_CR348","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12975-022-01017-4","volume":"14","author":"L Silva","year":"2023","unstructured":"Silva L, Vargas C, Prados ME, Del Pozo A, Villa M, Mart\u00ednez M, Alvarez L, Mu\u00f1oz E et al (2023) Neuroprotective efficacy of betulinic acid hydroxamate, a B55\u03b1\/PP2A activator, in acute hypoxia-ischemia-induced brain damage in newborn rats. Transl Stroke Res 14(3):397\u2013408. https:\/\/doi.org\/10.1007\/s12975-022-01017-4","journal-title":"Transl Stroke Res"},{"issue":"1","key":"5772_CR349","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.12.35","volume":"8","author":"B Chen","year":"2020","unstructured":"Chen B, Zhao Y, Li W, Hang J, Yin M, Yu H (2020) Echinocystic acid provides a neuroprotective effect via the PI3K\/AKT pathway in intracerebral haemorrhage mice. Ann Transl Med 8(1):6. https:\/\/doi.org\/10.21037\/atm.2019.12.35","journal-title":"Ann Transl Med"},{"issue":"6","key":"5772_CR350","doi-asserted-by":"publisher","first-page":"e18131","DOI":"10.1111\/jcmm.18131","volume":"28","author":"CC Lu","year":"2024","unstructured":"Lu CC, Lin CY, Lu YY, Tsai HP, Lin CL, Wu CH (2024) CDDO regulates central and peripheral sensitization to attenuate post-herpetic neuralgia by targeting TRPV1\/PKC-\u03b4\/p-Akt signals. J Cell Mol Med 28(6):e18131. https:\/\/doi.org\/10.1111\/jcmm.18131","journal-title":"J Cell Mol Med"},{"issue":"4","key":"5772_CR351","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2014.01.101","volume":"444","author":"B Li","year":"2014","unstructured":"Li B, Abdalrahman A, Lai Y, Janicki JS, Ward KW, Meyer CJ, Wang XL, Tang D et al (2014) Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2. Biochem Biophys Res Commun 444(4):555\u2013561. https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.101","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"5772_CR352","doi-asserted-by":"publisher","first-page":"12253","DOI":"10.1096\/fj.201900217R","volume":"33","author":"H Nagasu","year":"2019","unstructured":"Nagasu H, Sogawa Y, Kidokoro K, Itano S, Yamamoto T, Satoh M, Sasaki T, Suzuki T et al (2019) Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function. FASEB J 33(11):12253\u201312263. https:\/\/doi.org\/10.1096\/fj.201900217R","journal-title":"FASEB J"},{"key":"5772_CR353","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.freeradbiomed.2017.04.027","volume":"108","author":"KJ Bubb","year":"2017","unstructured":"Bubb KJ, Kok C, Tang O, Rasko NB, Birgisdottir AB, Hansen T, Ritchie R, Bhindi R et al (2017) The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling. Free Radic Biol Med 108:585\u2013594. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.04.027","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5772_CR354","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jnc.13064","volume":"133","author":"Z Xu","year":"2015","unstructured":"Xu Z, Cho H, Hartsock MJ, Mitchell KL, Gong J, Wu L, Wei Y, Wang S et al (2015) Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion. J Neurochem 133(2):233\u2013241. https:\/\/doi.org\/10.1111\/jnc.13064","journal-title":"J Neurochem"},{"issue":"1","key":"5772_CR355","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.toxlet.2015.07.005","volume":"238","author":"A Speen","year":"2015","unstructured":"Speen A, Jones C, Patel R, Shah H, Nallasamy P, Brooke EA, Zhu H, Li YR et al (2015) Mechanisms of CDDO-imidazolide-mediated cytoprotection against acrolein-induced neurocytotoxicity in SH-SY5Y cells and primary human astrocytes. Toxicol Lett 238(1):32\u201342. https:\/\/doi.org\/10.1016\/j.toxlet.2015.07.005","journal-title":"Toxicol Lett"},{"key":"5772_CR356","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065875","author":"DS Lee","year":"2023","unstructured":"Lee DS, Kim TH, Park H, Kim JE (2023) CDDO-Me abrogates aberrant mitochondrial elongation in clasmatodendritic degeneration by regulating NF-\u03baB-PDI-Mediated S-nitrosylation of DRP1. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24065875","journal-title":"Int J Mol Sci"},{"key":"5772_CR357","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194862","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Park H, Choi SH, Kong MJ, Kim JE, Kang TC (2019) CDDO-Me attenuates vasogenic edema and astroglial death by regulating NF-\u03baB p65 phosphorylations and Nrf2 expression following status epilepticus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20194862","journal-title":"Int J Mol Sci"},{"key":"5772_CR358","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081850","author":"Q Guo","year":"2021","unstructured":"Guo Q, Wang B, Wang X, Smith WW, Zhu Y, Liu Z (2021) Activation of Nrf2 in astrocytes suppressed PD-like phenotypes via antioxidant and autophagy pathways in rat and drosophila models. Cells. https:\/\/doi.org\/10.3390\/cells10081850","journal-title":"Cells"},{"key":"5772_CR359","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.01.004","volume":"59","author":"D Camer","year":"2015","unstructured":"Camer D, Yu Y, Szabo A, Fernandez F, Dinh CHL, Huang XF (2015) Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory. Prog Neuropsychopharmacol Biol Psychiatry 59:68\u201375. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.01.004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"5772_CR360","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s12035-024-04361-8","volume":"62","author":"Z Liu","year":"2025","unstructured":"Liu Z, Jia J (2025) Omaveloxolone ameliorates cognitive deficits by inhibiting apoptosis and neuroinflammation in APP\/PS1 mice. Mol Neurobiol 62(2):2191\u20132202. https:\/\/doi.org\/10.1007\/s12035-024-04361-8","journal-title":"Mol Neurobiol"},{"issue":"5","key":"5772_CR361","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/brain\/awy071","volume":"141","author":"T Shekh-Ahmad","year":"2018","unstructured":"Shekh-Ahmad T, Eckel R, Dayalan Naidu S, Higgins M, Yamamoto M, Dinkova-Kostova AT, Kovac S, Abramov AY et al (2018) Keap1 inhibition is neuroprotective and suppresses the development of epilepsy. Brain 141(5):1390\u20131403. https:\/\/doi.org\/10.1093\/brain\/awy071","journal-title":"Brain"},{"key":"5772_CR362","doi-asserted-by":"publisher","first-page":"1539032","DOI":"10.3389\/fphar.2025.1539032","volume":"16","author":"X Guo","year":"2025","unstructured":"Guo X, Wang J, Fan H, Tao W, Ren Z, Li X, Liu S, Zhou P et al (2025) Computational drug repurposing in Parkinson\u2019s disease: omaveloxolone and cyproheptadine as promising therapeutic candidates. Front Pharmacol 16:1539032. https:\/\/doi.org\/10.3389\/fphar.2025.1539032","journal-title":"Front Pharmacol"},{"key":"5772_CR363","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122261","volume":"335","author":"X Cui","year":"2023","unstructured":"Cui X, Zong S, Song W, Wang C, Liu Y, Zhang L, Xia P, Wang X et al (2023) Omaveloxolone ameliorates cognitive dysfunction in APP\/PS1 mice by stabilizing the STAT3 pathway. Life Sci 335:122261. https:\/\/doi.org\/10.1016\/j.lfs.2023.122261","journal-title":"Life Sci"},{"key":"5772_CR364","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.nbd.2023.106210","volume":"184","author":"B Yang","year":"2023","unstructured":"Yang B, Pan J, Zhang XN, Wang H, He L, Rong X, Li X, Peng Y (2023) NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1(G93A) mutation and exerts neuroprotection in amyotrophic lateral sclerosis. Neurobiol Dis 184:106210. https:\/\/doi.org\/10.1016\/j.nbd.2023.106210","journal-title":"Neurobiol Dis"},{"key":"5772_CR365","doi-asserted-by":"publisher","unstructured":"Lin X, Wang H, Zou L, Yang B, Chen W, Rong X, Zhang X, He L et al (2024) The NRF2 activator RTA-408 ameliorates chronic alcohol exposure-induced cognitive impairment and NLRP3 inflammasome activation by modulating impaired mitophagy initiation. Free Radic Biol Med 220:15\u201327. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.236","DOI":"10.1016\/j.freeradbiomed.2024.04.236"},{"issue":"1","key":"5772_CR366","doi-asserted-by":"publisher","first-page":"e01918","DOI":"10.1002\/brb3.1918","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhou Q, Zhou CL (2021) RTA-408 protects against propofol-induced cognitive impairment in neonatal mice via the activation of Nrf2 and the inhibition of NF-\u03baB p65 nuclear translocation. Brain Behav 11(1):e01918. https:\/\/doi.org\/10.1002\/brb3.1918","journal-title":"Brain Behav"},{"issue":"10","key":"5772_CR367","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240122","volume":"15","author":"TH Tsai","year":"2020","unstructured":"Tsai TH, Lin SH, Wu CH, Tsai YC, Yang SF, Lin CL (2020) Mechanisms and therapeutic implications of RTA 408, an activator of Nrf2, in subarachnoid hemorrhage-induced delayed cerebral vasospasm and secondary brain injury. PLoS ONE 15(10):e0240122. https:\/\/doi.org\/10.1371\/journal.pone.0240122","journal-title":"PLoS ONE"},{"key":"5772_CR368","doi-asserted-by":"publisher","first-page":"9577874","DOI":"10.1155\/2021\/9577874","volume":"2021","author":"J Sun","year":"2021","unstructured":"Sun J, Li JY, Zhang LQ, Li DY, Wu JY, Gao SJ, Liu DQ, Zhou YQ et al (2021) Nrf2 activation attenuates chronic constriction injury-induced neuropathic pain via induction of PGC-1\u03b1-mediated mitochondrial biogenesis in the spinal cord. Oxid Med Cell Longev 2021:9577874. https:\/\/doi.org\/10.1155\/2021\/9577874","journal-title":"Oxid Med Cell Longev"},{"key":"5772_CR369","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2016.07.035","volume":"333","author":"K Yamauchi","year":"2016","unstructured":"Yamauchi K, Nakano Y, Imai T, Takagi T, Tsuruma K, Shimazawa M, Iwama T, Hara H (2016) A novel nuclear factor erythroid 2-related factor 2 (Nrf2) activator RS9 attenuates brain injury after ischemia reperfusion in mice. Neuroscience 333:302\u2013310. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.07.035","journal-title":"Neuroscience"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05772-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05772-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:02:30Z","timestamp":1774281750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05772-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":369,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5772"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05772-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Ethics Declaration"}}],"article-number":"516"}}